Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2014);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;9.351;Q1;210;27;71;3483;1444;70;20.55;129;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;9.338;Q1;348;227;655;8790;6585;297;9.36;38.72;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
3;21191;Pharmacological Reviews;journal;15210081, 00316997;9.152;Q1;241;26;105;12841;2368;105;19.31;493.88;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
4;4700152457;Nano Today;journal;17480132;7.152;Q1;155;68;192;5667;2408;121;9.77;83.34;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;5.062;Q1;225;83;268;6223;2654;236;10.2;74.98;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;4.877;Q1;331;137;462;20537;7720;413;15.56;149.91;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
7;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;4.048;Q1;211;107;314;21251;3276;313;11.03;198.61;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
8;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;3.821;Q1;227;324;812;16259;5943;743;6.82;50.18;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
9;12611;Drug Resistance Updates;journal;13687646, 15322084;3.578;Q1;119;9;63;904;687;59;10.03;100.44;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
10;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.454;Q1;233;311;891;35012;5759;885;6.08;112.58;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;26371;Natural Product Reports;journal;02650568, 14604752;3.42;Q1;188;92;218;12958;2316;213;9.85;140.85;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
12;19700176055;F1000 Biology Reports;journal;1757594X, 17404118;3.327;Q1;31;0;52;0;285;52;4.81;0;United Kingdom;Western Europe;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous)  (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
13;18148;Pain;journal;18726623, 03043959;3.326;Q1;269;377;1222;16324;6693;928;4.82;43.3;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
14;12455;Molecular Therapy;journal;15250024, 15250016;3.213;Q1;185;236;799;9297;4943;669;5.89;39.39;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.01;Q1;190;183;577;9291;3135;538;5.5;50.77;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;2.812;Q1;66;8;15;1415;101;15;6.73;176.88;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
17;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.64;Q1;195;214;753;6021;4642;693;6.44;28.14;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
18;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;2.639;Q1;43;18;58;279;316;56;5.35;15.5;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
19;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.534;Q1;134;39;97;6938;826;96;8.88;177.9;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
20;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.52;Q1;146;121;374;6944;1856;366;5.17;57.39;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
21;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.513;Q1;143;768;1592;38387;8657;1567;5.21;49.98;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
22;23010;Journal of Controlled Release;journal;18734995, 01683659;2.438;Q1;282;492;1476;32567;11181;1397;8.35;66.19;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
23;5100155080;Neurotherapeutics;journal;19337213;2.433;Q1;122;79;206;7345;1131;193;5.41;92.97;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
24;4400151524;Particle and Fibre Toxicology;journal;17438977;2.411;Q1;105;73;147;4148;1294;138;7.58;56.82;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
25;20435;Neuropharmacology;journal;00283908, 18737064;2.41;Q1;176;423;1166;32705;6283;1145;5.62;77.32;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
26;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.361;Q1;269;1071;2897;38142;14826;2714;4.98;35.61;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
27;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.298;Q1;203;705;1597;20669;8380;1319;5.19;29.32;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
28;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.298;Q1;202;159;632;8397;2978;631;4.53;52.81;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
29;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.24;Q1;276;766;2381;41086;14204;2362;5.73;53.64;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
30;19427;Advances in Pharmacology;journal;15578925, 10543589;2.233;Q1;78;46;104;6266;511;0;4.59;136.22;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
31;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;2.209;Q1;118;192;403;10696;2148;382;4.43;55.71;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
32;20084;British Journal of Pharmacology;journal;14765381, 00071188;2.202;Q1;223;425;1456;32394;7566;1416;5.06;76.22;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
33;24749;Addiction Biology;journal;13556215, 13691600;2.194;Q1;83;101;260;4998;1376;257;5.48;49.49;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
34;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;2.084;Q1;139;114;368;6585;1809;333;4.91;57.76;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
35;20063;Biochemical Pharmacology;journal;18732968, 00062952;2.079;Q1;206;331;1059;22692;5633;919;5.41;68.56;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
36;21100225611;Advanced healthcare materials;journal;21922640, 21922659;2.068;Q1;105;228;274;12736;1608;271;5.87;55.86;United Kingdom;Western Europe;John Wiley and Sons Ltd;2012-2021;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
37;21169;Pharmacological Research;journal;10436618, 10961186;2.031;Q1;147;106;429;7971;2256;417;5.46;75.2;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
38;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.99;Q1;94;116;380;11340;1795;367;4.78;97.76;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
39;23916;Environmental Pollution;journal;02697491, 18736424;1.987;Q1;249;460;1409;21850;7057;1382;4.52;47.5;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
40;26380;Drug and Alcohol Dependence;journal;03768716;1.977;Q1;173;404;1038;18844;4396;1023;3.98;46.64;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
41;21782;Psychopharmacology;journal;00333158, 14322072;1.955;Q1;202;424;1213;25865;5197;1159;4.01;61;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
42;21100207003;Theranostics;journal;18387640;1.955;Q1;115;97;200;6416;1621;181;8.11;66.14;Australia;Pacific Region;Ivyspring International Publisher;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
43;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.928;Q1;169;83;195;5545;1169;189;5.71;66.81;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
44;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.924;Q1;113;219;446;12164;2074;434;4.3;55.54;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
45;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.876;Q1;133;185;411;8577;3160;401;7.17;46.36;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
46;21196;Drug Discovery Today;journal;18785832, 13596446;1.865;Q1;185;251;468;16300;2896;431;6.42;64.94;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
47;25218;Toxicological Sciences;journal;10960929, 10966080;1.813;Q1;193;267;846;11104;4091;816;4.21;41.59;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
48;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.809;Q1;233;245;999;11517;4552;998;4.52;47.01;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
49;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.793;Q1;89;15;61;1958;363;56;5.11;130.53;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
50;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.792;Q1;159;362;818;15378;3444;772;3.88;42.48;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
51;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.789;Q1;134;187;723;13392;3192;677;4.2;71.61;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
52;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.778;Q1;39;46;95;1083;414;84;4.37;23.54;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
53;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.73;Q1;97;52;204;1909;858;196;4.34;36.71;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2)"
54;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;1.727;Q1;71;78;139;3914;649;127;4.67;50.18;United States;Northern America;Cell Press;2012-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
55;5400152706;Nanotoxicology;journal;17435390, 17435404;1.714;Q1;94;95;217;5108;1523;213;6.28;53.77;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
56;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.711;Q1;177;248;766;11267;4002;765;4.91;45.43;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
57;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.688;Q1;120;194;584;7592;2162;523;3.24;39.13;United States;Northern America;Landes Bioscience;2002-2021;"Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2)"
58;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.667;Q1;129;115;341;3652;1048;326;2.89;31.76;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
59;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.664;Q1;117;48;125;7062;724;112;4.91;147.13;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
60;24763;Addictive Behaviors;journal;03064603;1.663;Q1;135;304;704;13143;2407;701;3.22;43.23;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
61;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.659;Q1;121;134;471;7855;1962;446;4.35;58.62;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
62;19617;Antiviral Research;journal;01663542, 18729096;1.653;Q1;134;208;595;10857;2470;575;4.38;52.2;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
63;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.648;Q1;90;78;187;3479;931;187;4.78;44.6;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Molecular Medicine (Q1); Pharmacology (Q1); Genetics (Q2)"
64;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.647;Q1;96;118;361;13886;1461;340;3.8;117.68;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
65;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.641;Q1;138;426;1049;20701;5596;1037;5.02;48.59;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
66;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.633;Q1;100;30;89;4924;496;85;5.49;164.13;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
67;19600166320;Protein and Cell;journal;16748018, 1674800X;1.625;Q1;74;102;337;5133;991;314;3.03;50.32;China;Asiatic Region;Higher Education Press;2010-2021;"Biochemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Cell Biology (Q2)"
68;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.619;Q1;75;149;398;6211;1434;306;3.36;41.68;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1)"
69;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.61;Q1;96;87;231;3475;852;221;3.31;39.94;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
70;110172;Progress in Drug Research;book series;0071786X;1.595;Q1;44;23;15;2373;65;13;0;103.17;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
71;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.587;Q1;77;58;266;4312;946;255;4.08;74.34;United States;Northern America;Springer New York;2006-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
72;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.583;Q1;115;143;348;7421;1402;346;3.91;51.9;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
73;22378;Vascular Pharmacology;journal;18793649, 15371891;1.577;Q1;100;74;179;4003;721;164;3.99;54.09;United States;Northern America;Elsevier Inc.;2002-2021;"Molecular Medicine (Q1); Pharmacology (Q1); Physiology (Q1)"
74;21100214102;Frontiers in Pharmacology;journal;16639812;1.56;Q1;104;272;444;20945;1870;425;4.13;77;Switzerland;Western Europe;Frontiers Media S.A.;2010-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
75;21790;Antiviral Therapy;journal;20402058, 13596535;1.541;Q1;89;107;473;3662;1516;455;3.12;34.22;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
76;29311;Current Cancer Drug Targets;journal;15680096, 18735576;1.533;Q1;96;65;265;6080;1031;246;3.87;93.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1); Cancer Research (Q2)"
77;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.533;Q1;91;167;459;14550;1753;393;3.81;87.13;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Immunology (Q2)"
78;22072;Current Gene Therapy;journal;18755631, 15665232;1.503;Q1;75;45;141;3701;508;127;2.85;82.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
79;24604;Archives of Toxicology;journal;14320738, 03405761;1.495;Q1;121;182;518;12205;2651;448;5.27;67.06;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
80;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.487;Q1;153;273;758;10601;2828;610;3.62;38.83;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
81;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.481;Q1;168;242;724;10773;3491;712;4.28;44.52;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
82;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.477;Q1;95;61;155;3142;496;153;3.04;51.51;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
83;145164;Human Genomics;journal;14739542, 14797364;1.446;Q1;59;21;86;778;277;79;2.2;37.05;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
84;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.445;Q1;163;212;693;11122;2882;670;3.94;52.46;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
85;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.434;Q1;175;306;995;15186;4296;989;4.31;49.63;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
86;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.431;Q1;109;140;442;11529;1733;434;4.17;82.35;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
87;84948;Expert Opinion on Drug Delivery;journal;17425247;1.423;Q1;116;144;357;12018;1866;351;5.11;83.46;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
88;19600166302;Current Molecular Pharmacology;journal;18744702;1.419;Q1;42;18;77;1656;261;69;2.78;92;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
89;18071;Neurotoxicity Research;journal;14763524, 10298428;1.4;Q1;78;73;241;4589;913;239;3.97;62.86;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
90;20664;Current Drug Targets;journal;18735592, 13894501;1.395;Q1;107;118;561;12855;1967;508;3.19;108.94;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
91;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.389;Q1;53;86;270;4748;936;261;3.38;55.21;United States;Northern America;Springer New York;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
92;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;1.385;Q1;103;71;220;3797;852;209;3.28;53.48;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
93;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.35;Q1;213;282;818;12516;3635;793;4.02;44.38;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
94;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.347;Q1;229;746;2216;28029;10041;2175;4.17;37.57;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
95;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.343;-;144;77;302;3055;1205;297;3.84;39.68;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
96;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.326;Q1;91;162;487;11723;1864;476;3.94;72.36;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
97;23053;Journal of Natural Products;journal;01633864, 15206025;1.326;Q1;147;379;1058;12318;4276;1052;4.1;32.5;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
98;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.323;Q1;103;128;348;5367;1027;309;2.93;41.93;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
99;4000148406;Clinical Toxicology;journal;15569519, 15563650;1.318;Q1;98;148;462;3982;1421;335;2.76;26.91;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
100;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;1.31;Q1;77;102;324;8692;1268;323;4.42;85.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
101;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.306;Q1;145;492;1274;20753;6721;1259;4.95;42.18;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Organic Chemistry (Q1)"
102;18966;Mutagenesis;journal;02678357, 14643804;1.304;Q1;95;56;274;2193;1012;269;2.95;39.16;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
103;144771;Clinical Trials;journal;17407753, 17407745;1.302;Q1;67;84;281;2004;484;232;1.84;23.86;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
104;4000148019;AAPS Journal;journal;15507416;1.298;Q1;118;128;283;4985;1327;274;4.32;38.95;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
105;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.298;Q1;78;109;297;2587;909;284;3.21;23.73;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
106;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.295;Q1;66;122;206;3932;524;152;2.53;32.23;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
107;18073;NeuroToxicology;journal;18729711, 0161813X;1.293;Q1;122;149;443;8236;1609;426;3.61;55.28;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
108;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.293;Q1;36;5;17;534;61;1;3.27;106.8;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
109;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.292;Q1;166;633;1649;76138;6027;1520;3.5;120.28;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
110;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.282;Q1;183;322;1293;39596;5358;1224;4.1;122.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
111;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.276;Q1;39;46;193;880;295;177;0.94;19.13;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
112;24028;Reproductive Toxicology;journal;08906238, 18731708;1.274;Q1;117;141;418;6716;1561;389;3.61;47.63;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q1)
113;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.267;Q1;56;25;86;1144;353;83;3.9;45.76;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Neurology (Q2)"
114;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.254;Q1;76;22;157;1069;433;151;2.46;48.59;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Cell Biology (Q2); Physiology (Q2)"
115;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.252;Q1;182;243;820;10383;3126;813;3.71;42.73;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
116;25075;Ecotoxicology;journal;09639292, 15733017;1.239;Q1;97;202;569;9990;1700;565;2.76;49.46;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
117;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.239;Q1;70;43;154;2263;474;144;3.08;52.63;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
118;21237;Drug Safety;journal;01145916, 11791942;1.238;Q1;131;95;321;4352;1057;282;3.29;45.81;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
119;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.231;Q1;73;239;609;5933;1887;599;3.06;24.82;United States;Northern America;American Chemical Society;2010-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
120;25219;Toxicology;journal;0300483X, 18793185;1.23;Q1;165;136;634;7352;2522;614;3.84;54.06;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
121;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.222;Q1;71;70;211;2300;592;177;2.81;32.86;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
122;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.212;Q1;82;44;177;5733;572;168;3.29;130.3;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2)"
123;21165;PharmacoEconomics;journal;11707690, 11792027;1.203;Q1;104;108;270;4933;703;232;2.47;45.68;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
124;21100788810;Chemotherapy Research and Practice;journal;20902107;1.202;Q1;5;3;1;139;4;1;0;46.33;United States;Northern America;;;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Oncology (Q2)"
125;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.198;Q1;114;183;666;6745;2097;569;3.13;36.86;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
126;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.196;Q1;205;688;2045;35654;7931;2032;3.64;51.82;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q1)"
127;21100232818;Emerging Microbes and Infections;journal;22221751;1.165;Q1;68;48;65;2923;147;60;2.26;60.9;United Kingdom;Western Europe;Nature Publishing Group;2012-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Parasitology (Q1); Epidemiology (Q2); Immunology (Q2); Infectious Diseases (Q2); Microbiology (Q2); Virology (Q2)"
128;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;1.155;Q1;79;140;386;4594;935;381;2.41;32.81;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Pharmacology (Q1); Biochemistry (Q2); Molecular Medicine (Q2)"
129;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.154;Q1;68;107;285;10590;999;285;3.76;98.97;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q1)
130;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.149;Q1;122;234;703;18714;2533;624;3.3;79.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
131;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;1.149;Q1;50;61;108;3670;404;105;3.74;60.16;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine (Q1); Pharmacology (Q1)"
132;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.149;Q1;139;259;785;16888;2431;783;3.07;65.2;United States;Northern America;Elsevier Inc.;1973-2021;"Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2); Clinical Biochemistry (Q2)"
133;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.142;Q1;40;40;55;2804;208;54;3.57;70.1;Netherlands;Western Europe;Elsevier BV;2011-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Infectious Diseases (Q2); Parasitology (Q2)"
134;25240;Toxicology Letters;journal;03784274, 18793169;1.142;Q1;150;362;898;16919;3381;879;3.54;46.74;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
135;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.141;Q1;114;285;960;8854;3087;938;3.34;31.07;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Toxicology (Q2)"
136;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.137;Q1;76;15;38;2511;164;38;5.07;167.4;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
137;21100225613;Human gene therapy methods;journal;19466536, 19466544;1.135;Q1;31;35;79;1603;209;79;2.65;45.8;United States;Northern America;Mary Ann Liebert Inc.;2012-2019;"Applied Microbiology and Biotechnology (Q1); Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3)"
138;19700178100;Nanotechnology, Science and Applications;journal;11778903;1.131;Q1;30;6;18;604;117;18;7.75;100.67;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Nanoscience and Nanotechnology (Q2)"
139;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;1.114;Q1;76;171;563;11950;1511;450;2.43;69.88;United Kingdom;Western Europe;Future Science;2009-2021;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
140;4400151608;ChemMedChem;journal;18607187, 18607179;1.11;Q1;106;320;688;12177;1928;668;2.75;38.05;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
141;4400151410;Human Vaccines;journal;15548600, 15548619;1.11;Q1;58;0;264;0;734;199;0;0;United States;Northern America;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q2)"
142;16088;Journal of Nanobiotechnology;journal;14773155;1.109;Q1;84;59;153;2388;738;152;4.42;40.47;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
143;22477;Investigational New Drugs;journal;01676997, 15730646;1.093;Q1;90;142;622;4435;2012;618;3.27;31.23;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
144;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1.092;Q1;46;22;81;3347;271;74;4.48;152.14;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
145;4700152848;PPAR Research;journal;16874757, 16874765;1.091;Q1;52;31;139;1330;375;133;2.76;42.9;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
146;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;1.079;Q1;175;894;1992;41622;8163;1991;3.87;46.56;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
147;20473;Life Sciences;journal;18790631, 00243205;1.074;Q1;174;385;935;17353;2738;925;2.97;45.07;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
148;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.07;Q1;90;196;362;18231;973;313;2.46;93.02;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
149;22432;International Immunopharmacology;journal;18781705, 15675769;1.061;Q1;119;383;931;16236;2881;913;2.83;42.39;Netherlands;Western Europe;Elsevier;2001-2021;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
150;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;1.061;Q1;52;56;168;3331;457;163;2.55;59.48;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
151;22411;Inflammopharmacology;journal;09254692, 15685608;1.056;Q2;55;36;113;2031;394;108;3.79;56.42;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (medical) (Q1); Immunology (Q2); Pharmacology (Q2)"
152;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.056;Q1;133;528;1377;18494;4586;1366;3.25;35.03;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Clinical Biochemistry (Q2)"
153;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.054;Q2;98;163;588;5725;1519;573;2.68;35.12;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
154;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.051;Q2;83;77;262;5435;665;259;2.57;70.58;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Psychiatry and Mental Health (Q1); Pharmacology (Q2)"
155;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1.051;Q2;48;46;203;1736;551;194;2.75;37.74;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
156;17067;Phytomedicine;journal;09447113, 1618095X;1.043;Q1;127;236;577;7900;2101;567;3.56;33.47;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
157;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;1.042;Q2;107;132;423;5878;1006;366;2.36;44.53;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
158;25096;Food and Chemical Toxicology;journal;18736351, 02786915;1.038;Q2;183;464;2011;22065;6874;1930;3.24;47.55;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
159;19700175230;Drug Design, Development and Therapy;journal;11778881;1.034;Q1;71;235;227;10969;865;227;3.5;46.68;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
160;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;1.034;Q2;52;76;216;1465;627;177;3.4;19.28;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
161;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.027;Q2;189;632;2023;30433;6089;2017;2.87;48.15;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
162;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.025;Q1;104;98;299;4819;957;287;3.14;49.17;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
163;20663;Current Drug Metabolism;journal;18755453, 13892002;1.014;Q2;111;70;329;8760;1116;291;3.2;125.14;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q2); Pharmacology (Q2)"
164;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.01;Q1;171;680;2365;28000;7438;2353;3.06;41.18;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
165;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.008;Q1;144;251;705;12147;2697;694;3.86;48.39;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
166;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;1.007;Q1;49;126;281;6416;642;234;2.1;50.92;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical) (Q1); Drug Discovery (Q1); Clinical Biochemistry (Q2)"
167;26767;Altex;journal;1868596X, 18688551;1.006;Q2;57;52;111;2399;378;85;3.39;46.13;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
168;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;1.005;Q1;88;131;630;10371;1748;573;2.42;79.17;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
169;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1;Q1;186;423;1324;18315;4324;1256;2.94;43.3;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
170;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.997;Q2;121;170;558;4423;1527;525;2.73;26.02;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
171;24652;Chemico-Biological Interactions;journal;00092797;0.995;Q2;128;240;552;11105;1628;532;2.83;46.27;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
172;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.994;Q2;15;1;3;23;9;3;3;23;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
173;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.992;Q2;104;142;476;6654;1167;456;2.26;46.86;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
174;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.991;Q1;95;92;276;4698;880;271;3.16;51.07;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
175;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.986;Q1;73;61;119;2495;356;116;2.6;40.9;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
176;19700188352;Toxins;journal;20726651;0.984;Q2;91;187;359;10068;1172;356;3.17;53.84;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
177;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.983;Q2;25;13;26;713;105;26;4.21;54.85;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Medicine (miscellaneous) (Q1); Reviews and References (medical) (Q1); Pharmacology (Q2)"
178;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.982;Q2;51;41;129;3944;386;126;3.13;96.2;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.977;Q2;47;82;105;4660;296;102;3.11;56.83;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q1); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
180;29712;Clinical Therapeutics;journal;1879114X, 01492918;0.976;Q2;140;221;652;7409;1823;592;3.04;33.52;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
181;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.975;Q1;58;62;274;1562;308;139;0.81;25.19;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q1); Molecular Medicine (Q2)"
182;26512;Tetrahedron;journal;14645416, 00404020;0.972;Q1;226;1140;3774;58436;11337;3760;2.92;51.26;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Drug Discovery (Q1); Biochemistry (Q2); Organic Chemistry (Q2)"
183;22319;Toxicon;journal;18793150, 00410101;0.972;Q2;133;235;745;10104;2012;727;2.65;43;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
184;20027;BMC Pharmacology;journal;14712210;0.968;Q2;44;0;22;0;59;22;4;0;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
185;21167;Pharmacogenomics;journal;14622416, 17448042;0.965;Q2;94;193;606;9357;1572;506;2.34;48.48;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
186;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.963;Q2;100;144;409;11251;1142;375;2.65;78.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Cancer Research (Q3)"
187;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.963;Q2;23;0;1;0;6;1;0;0;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
188;19034;Microbial Drug Resistance;journal;10766294, 19318448;0.959;Q2;72;90;247;3198;682;233;2.85;35.53;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
189;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.949;Q2;87;149;437;6116;1081;436;2.49;41.05;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
190;25224;Toxicology in Vitro;journal;18793177, 08872333;0.949;Q2;112;178;709;7639;2397;698;3.17;42.92;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
191;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.948;Q2;91;149;366;7893;1194;361;3.22;52.97;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
192;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.944;Q2;113;81;278;5000;810;276;2.48;61.73;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
193;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.944;Q2;34;18;60;1928;133;51;2.14;107.11;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
194;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.943;Q2;78;34;131;1411;363;128;2.54;41.5;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
195;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.942;Q1;154;1113;4287;32620;11308;4285;2.66;29.31;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
196;19700194010;MedChemComm;journal;20402503, 20402511;0.942;Q1;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Royal Society of Chemistry;2010-2019;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
197;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.941;Q1;48;77;249;1782;398;199;1.53;23.14;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q3)"
198;16573;Phytotherapy Research;journal;10991573, 0951418X;0.94;Q2;140;257;865;9955;2529;865;2.94;38.74;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
199;10900153302;Biomarker Insights;journal;11772719;0.937;Q2;35;13;48;424;132;48;2.77;32.62;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q1); Pharmacology (Q2); Molecular Medicine (Q3)"
200;22410;Inflammation Research;journal;1420908X, 10233830;0.935;Q2;94;108;410;4553;1017;405;2.55;42.16;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
201;21207;Drug Discovery Today: Technologies;journal;17406749;0.928;Q2;53;30;128;1482;331;114;2.75;49.4;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
202;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;0.924;Q2;69;532;721;21332;1601;547;2.22;40.1;United States;Northern America;Landes Bioscience;2012-2021;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
203;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.912;Q2;115;115;417;6154;995;417;2.13;53.51;United States;Northern America;Springer New York;1973-2021;"Medicine (miscellaneous) (Q1); Pollution (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
204;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.906;Q2;88;127;375;11853;1226;373;3.27;93.33;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
205;25109;Inhalation Toxicology;journal;08958378, 10917691;0.906;Q2;90;82;292;3829;785;280;2.57;46.7;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
206;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.901;Q2;31;36;38;2605;122;38;3.41;72.36;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
207;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.9;Q2;93;136;341;5540;845;334;2.45;40.74;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
208;18077;Fitoterapia;journal;0367326X, 18736971;0.897;Q2;110;266;700;8676;2094;698;2.84;32.62;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
209;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.893;Q1;69;79;237;2444;614;205;2.7;30.94;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
210;25214;Toxicologic Pathology;journal;15331601, 01926233;0.893;Q2;112;119;336;5551;818;322;2.34;46.65;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
211;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.89;Q2;39;33;135;1508;426;131;2.65;45.7;Egypt;Africa/Middle East;Hindawi Limited;2010-2021;"Pharmacology (Q2); Toxicology (Q2)"
212;14805;Steroids;journal;0039128X, 18785867;0.889;Q2;107;173;594;8211;1700;585;2.83;47.46;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
213;20026;BMC Clinical Pharmacology;journal;14726904;0.883;Q2;39;0;37;0;113;37;3.29;0;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
214;20051;BioDrugs;journal;11738804, 1179190X;0.875;Q2;71;48;146;2839;408;144;3.39;59.15;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
215;24785;Alcohol;journal;07418329;0.873;Q2;83;79;234;4632;604;228;2.5;58.63;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
216;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;0.87;Q1;46;100;218;6825;534;185;2.17;68.25;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
217;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.857;Q2;92;125;377;5797;947;367;2.72;46.38;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
218;16533;Phytochemical Analysis;journal;09580344, 10991565;0.846;Q2;76;69;256;2355;741;254;2.64;34.13;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Plant Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
219;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.833;Q2;75;71;205;2628;517;201;2.63;37.01;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
220;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.828;Q2;63;109;275;9714;769;247;2.45;89.12;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
221;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.824;Q1;57;167;394;6349;1063;359;2.39;38.02;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Spectroscopy (Q2)"
222;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.823;Q2;62;83;292;2795;420;286;1.36;33.67;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
223;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.818;Q1;38;27;73;1290;220;71;2.65;47.78;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
224;4000150314;Chemical Biology and Drug Design;journal;17470277;0.818;-;82;153;543;5433;1456;524;2.58;35.51;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q3)"
225;19700175143;Pharmacognosy Reviews (discontinued);journal;09737847, 09762787;0.817;Q2;54;19;69;1377;211;68;1.91;72.47;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018;"Complementary and Alternative Medicine (Q1); Plant Science (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
226;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.814;Q2;64;26;99;1323;278;99;3.11;50.88;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
227;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.814;Q2;51;43;178;3300;412;163;2.11;76.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Immunology and Allergy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
228;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.814;Q1;21;61;45;475;64;31;1.33;7.79;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2021;"Health Policy (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
229;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.808;Q2;55;33;133;1828;250;120;1.71;55.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
230;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.808;Q2;94;26;172;1224;442;166;2.83;47.08;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
231;26514;Tetrahedron Letters;journal;00404039, 18733581;0.796;Q2;173;1633;5074;61018;13333;5072;2.6;37.37;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
232;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.791;Q2;64;119;353;4821;689;332;1.85;40.51;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
233;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.79;Q2;66;85;95;4196;228;91;2.34;49.36;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
234;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.788;Q2;109;156;317;5899;770;312;2.37;37.81;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
235;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.785;Q2;70;59;378;2551;930;372;2.43;43.24;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
236;19374;AAPS PharmSciTech;journal;15309932;0.783;Q1;101;165;462;6569;1204;462;2.07;39.81;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
237;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.783;Q2;90;198;556;7972;1193;547;2.08;40.26;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
238;144790;Marine Drugs;journal;16603397;0.78;Q2;128;340;674;19323;2622;674;3.2;56.83;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q2)
239;19700175015;Infection and Drug Resistance;journal;11786973;0.777;Q2;44;35;71;2165;170;70;2.26;61.86;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
240;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.774;Q1;122;291;986;9325;2222;969;2.09;32.04;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
241;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.774;Q2;81;90;254;5055;789;254;2.64;56.17;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
242;6400153120;Chinese Medicine;journal;17498546;0.771;Q2;45;27;93;1337;262;90;2;49.52;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
243;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.769;Q2;95;95;412;8756;1379;393;3.18;92.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
244;17700156714;Pharmaceuticals;journal;14248247;0.765;Q1;69;56;239;3813;521;239;2.46;68.09;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Pharmaceutical Science (Q1); Molecular Medicine (Q3)"
245;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.764;Q2;83;244;750;16940;2020;718;2.9;69.43;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
246;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.764;Q2;80;213;596;7351;1428;587;2.1;34.51;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
247;21744;Planta Medica;journal;14390221, 00320943;0.762;Q1;122;190;734;6845;1767;723;2.16;36.03;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
248;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.76;Q2;21;0;7;0;19;7;0;0;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
249;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.76;Q2;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
250;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.759;Q1;38;36;99;629;199;81;1.58;17.47;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;Pharmaceutical Science (Q1)
251;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.758;Q1;26;3;42;314;79;39;0.65;104.67;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Pharmaceutical Science (Q1); Molecular Biology (Q3)"
252;25093;Environmental Toxicology;journal;15227278, 15204081;0.757;Q2;81;146;226;7062;568;225;2.51;48.37;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
253;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.75;Q1;80;261;524;25186;2464;521;5.56;96.5;United States;Northern America;American Scientific Publishers;2007-2020;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
254;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.75;Q2;112;215;447;9398;1167;422;2.36;43.71;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
255;20634;Journal of Texture Studies;journal;00224901, 17454603;0.748;Q1;57;48;141;1654;273;138;1.6;34.46;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q1); Pharmaceutical Science (Q1)"
256;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.747;Q2;93;152;398;6131;949;380;2.4;40.34;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
257;130063;Pharmacological Reports;journal;17341140;0.747;Q2;87;165;490;7089;1154;488;2.22;42.96;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
258;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.744;Q2;96;148;398;5845;859;389;2.06;39.49;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
259;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.743;Q1;18;4;24;233;78;23;1.45;58.25;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
260;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.738;Q2;76;111;318;3633;726;315;2.25;32.73;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
261;26370;Molecules;journal;14203049;0.738;Q1;171;1293;2822;60182;8395;2816;2.81;46.54;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
262;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.737;Q2;52;83;256;1684;202;242;0.64;20.29;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
263;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.733;Q2;25;24;58;1267;94;52;1.6;52.79;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Health Policy (Q2); Pharmacology (Q2)"
264;20570;Chemotherapy;journal;00093157, 14219794;0.724;Q2;58;76;158;2259;339;155;2.41;29.72;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Oncology (Q3)"
265;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.723;Q2;12;34;17;4144;23;13;2.22;121.88;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
266;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.719;Q2;87;159;429;7526;826;412;2.04;47.33;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
267;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.719;Q2;96;129;347;3575;822;309;2.31;27.71;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
268;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.716;Q2;56;38;128;1376;293;124;2.1;36.21;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
269;21100218055;"BMC pharmacology &amp; toxicology";journal;20506511;0.715;Q2;34;77;83;2511;191;79;2.3;32.61;United Kingdom;Western Europe;BioMed Central Ltd.;2012-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
270;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.711;Q2;62;71;182;2737;408;181;2.23;38.55;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
271;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.711;Q1;124;180;557;7269;1443;551;2.57;40.38;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
272;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.705;Q2;40;52;137;2357;312;134;2.27;45.33;United States;Northern America;Informa Healthcare;2004-2021;"Toxicology (Q2); Immunology (Q3)"
273;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.7;Q2;77;73;242;3202;541;242;2.26;43.86;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
274;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.699;Q2;64;51;157;1999;321;150;2.15;39.2;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
275;19700175819;Patient Preference and Adherence;journal;1177889X;0.695;Q1;54;176;284;6644;655;281;2.27;37.75;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
276;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.693;Q2;88;252;504;11239;1281;504;2.44;44.6;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
277;19700200821;Therapeutic Delivery;journal;20415990, 20416008;0.692;Q1;52;113;407;6787;939;369;2.57;60.06;United Kingdom;Western Europe;Future Science;2010-2021;Pharmaceutical Science (Q1)
278;19700188217;Bioanalysis;journal;17576180, 17576199;0.686;Q1;62;319;925;12404;2112;738;2.16;38.88;United Kingdom;Western Europe;Future Science;2009-2021;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Medicine (miscellaneous) (Q2); Clinical Biochemistry (Q3)"
279;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.683;Q2;42;35;90;1437;195;90;2;41.06;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Safety Research (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
280;14822;Xenobiotica;journal;00498254, 13665928;0.681;Q2;82;119;350;4645;791;343;2.27;39.03;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
281;21100241601;Toxicology Research;journal;2045452X, 20454538;0.678;Q3;37;61;60;3111;228;56;3.8;51;United Kingdom;Western Europe;Oxford University Press;2012-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
282;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.677;Q2;54;12;47;573;116;45;2.17;47.75;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
283;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.677;Q2;34;15;54;654;89;54;1.71;43.6;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
284;130047;Current Drug Discovery Technologies;journal;15701638;0.668;Q2;44;26;105;1787;224;96;1.63;68.73;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
285;19700188360;Pharmaceutics;journal;19994923;0.667;Q1;68;35;120;2168;324;120;2.34;61.94;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science (Q1)
286;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.666;Q2;80;49;179;1127;426;171;2.47;23;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
287;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.664;Q2;93;178;682;6435;1646;679;2.43;36.15;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
288;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.663;Q3;40;49;116;2205;259;112;2.29;45;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
289;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.66;Q2;42;33;67;2056;110;62;1.78;62.3;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
290;20770;Drug Delivery;journal;10717544, 15210464;0.66;Q1;72;66;166;2705;346;156;2.21;40.98;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
291;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.66;Q3;53;98;338;3016;556;261;1.59;30.78;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
292;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.659;Q2;90;120;366;4815;571;358;1.48;40.13;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Computational Theory and Mathematics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
293;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.652;Q1;81;38;145;2768;364;145;2.28;72.84;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
294;23039;Journal of Liposome Research;journal;08982104, 15322394;0.65;Q1;53;37;111;1425;216;111;2.06;38.51;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q1)
295;15840;Journal of Antibiotics;journal;00218820, 18811469;0.649;Q2;84;146;378;4439;773;357;1.83;30.4;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
296;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.649;Q1;50;110;315;3237;624;315;2.04;29.43;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
297;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.64;Q1;46;46;145;2050;279;130;1.59;44.57;United States;Northern America;Springer Publishing Company;2011-2021;Pharmaceutical Science (Q1)
298;23942;Biomedical Chromatography;journal;10990801, 02693879;0.638;Q2;68;240;628;6599;1213;619;1.86;27.5;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Molecular Biology (Q3)"
299;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.638;Q2;63;64;277;1853;565;273;2.04;28.95;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3)"
300;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.637;Q1;61;48;149;2036;413;143;2.69;42.42;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
301;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.631;Q2;25;23;73;1754;180;70;2.29;76.26;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Endocrinology, Diabetes and Metabolism (Q2); Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3)"
302;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.63;Q2;99;345;1067;5198;1292;604;1.21;15.07;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
303;25898;Journal of Peptide Science;journal;10752617, 10991387;0.625;Q2;68;116;313;5556;570;309;1.64;47.9;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Structural Biology (Q3); Molecular Biology (Q4)"
304;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.623;Q2;27;0;42;0;38;37;0.85;0;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q2); Molecular Medicine (Q3)"
305;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.622;Q1;63;166;378;5107;678;364;1.7;30.77;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
306;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.619;Q2;79;132;379;4894;750;377;2.18;37.08;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
307;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.619;Q1;59;116;112;5592;222;106;2.02;48.21;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Chemical Health and Safety (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
308;25106;Human and Experimental Toxicology;journal;09603271;0.616;Q3;82;130;506;5476;945;493;1.92;42.12;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
309;21194;Pharmacology;journal;00317012, 14230313;0.612;Q2;60;89;254;2601;443;252;1.74;29.22;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
310;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.609;Q2;54;85;194;3256;327;167;1.59;38.31;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
311;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.607;Q2;65;52;132;1692;411;129;3.2;32.54;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
312;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.603;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
313;130025;Current Drug Delivery;journal;15672018;0.599;Q2;65;74;212;4622;437;203;1.72;62.46;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q2)
314;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0.598;Q2;18;31;124;674;88;121;0.68;21.74;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Pharmaceutical Science (Q2); Statistics and Probability (Q3)"
315;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.595;Q3;76;264;968;6070;1457;968;1.41;22.99;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
316;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.589;Q2;26;20;111;651;193;103;1.76;32.55;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2)"
317;29053;Molecular Diversity;journal;1573501X, 13811991;0.588;Q2;58;69;243;3085;559;240;1.99;44.71;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q4)"
318;16067;Reading Teacher;journal;00340561;0.576;Q2;53;82;247;1741;275;219;1.25;21.23;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
319;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.574;Q2;81;96;246;3699;493;246;1.77;38.53;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2)"
320;16948;Chirality;journal;1520636X, 08990042;0.572;Q2;80;111;416;4208;759;412;1.92;37.91;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3); Pharmacology (Q3)"
321;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.569;Q3;33;72;201;2839;324;201;1.62;39.43;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q3); Physiology (Q3)"
322;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.564;Q2;39;68;183;1443;238;162;1.05;21.22;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q2)"
323;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.559;Q1;36;30;90;1514;163;79;1.81;50.47;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
324;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.558;Q3;46;82;262;3883;488;256;1.87;47.35;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
325;21100258853;F1000Research;journal;20461402;0.545;Q1;72;282;198;9262;152;193;0.77;32.84;United Kingdom;Western Europe;;2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
326;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.545;Q2;66;74;242;2763;428;237;1.65;37.34;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3)"
327;19700201201;EPMA Journal;journal;18785077, 18785085;0.543;Q2;39;21;71;1104;145;64;4.19;52.57;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2021;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Health Policy (Q2)"
328;21264;Drugs in R and D;journal;11796901, 11745886;0.541;Q3;47;39;88;1178;171;85;1.52;30.21;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
329;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.54;Q2;72;223;578;8232;1025;578;1.55;36.91;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
330;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.534;Q3;34;32;99;1286;176;97;1.63;40.19;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
331;13671;Biologicals;journal;10958320, 10451056;0.533;Q3;60;48;226;1779;364;220;1.46;37.06;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
332;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.532;Q2;74;90;190;3147;310;186;1.38;34.97;United States;Northern America;Wiley-Blackwell;1986-2021;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
333;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.532;Q3;40;26;99;1555;137;92;1.23;59.81;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Hematology (Q3); Pharmacology (Q3)"
334;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.531;Q3;53;54;337;2247;541;329;1.55;41.61;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
335;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.531;Q3;67;118;377;1887;416;344;1.07;15.99;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
336;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.529;Q2;29;8;33;356;76;33;2;44.5;United States;Northern America;Springer Science + Business Media;2010-2021;"Biomedical Engineering (Q2); Pharmaceutical Science (Q2); Oncology (Q3); Physical and Theoretical Chemistry (Q3)"
337;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.529;Q2;40;67;194;1451;192;163;1.05;21.66;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
338;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.528;Q2;65;97;286;3914;528;286;1.78;40.35;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
339;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.526;Q2;47;78;235;2556;406;212;1.77;32.77;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
340;21100239265;PharmaNutrition;journal;22134344;0.525;Q3;23;21;26;829;54;24;2.08;39.48;Netherlands;Western Europe;Elsevier BV;2013-2021;"Food Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
341;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.52;Q3;32;40;93;2503;152;87;1.6;62.58;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
342;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.518;Q3;52;76;202;1953;334;170;1.79;25.7;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
343;22205;Saudi Pharmaceutical Journal;journal;13190164;0.513;Q2;57;80;135;2525;292;133;1.96;31.56;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
344;24578;Mathematical Medicine and Biology;journal;14778599;0.512;Q3;46;19;56;764;86;54;1.41;40.21;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
345;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;0.512;Q2;42;144;158;3760;270;150;1.49;26.11;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
346;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.509;Q2;62;117;316;4033;455;313;1.36;34.47;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
347;19900192900;Molecular Informatics;journal;18681751, 18681743;0.508;Q2;70;71;247;3270;435;238;1.83;46.06;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
348;25171;Mycotoxin Research;journal;18671632, 01787888;0.508;Q3;40;27;100;971;159;99;1.3;35.96;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q2); Microbiology (Q3); Toxicology (Q3)"
349;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.497;Q1;91;144;500;4961;708;497;1.25;34.45;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
350;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.494;Q3;58;93;506;1965;802;503;1.58;21.13;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
351;19700181240;Global Journal of Pharmacology (discontinued);journal;19920075;0.493;Q1;18;26;90;847;77;90;0.78;32.58;Pakistan;Asiatic Region;International Digital Organization for Scientific Information;2010-2014;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
352;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.489;Q2;38;13;68;354;98;65;1.62;27.23;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Cancer Research (Q3); Pharmacology (Q3)"
353;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;0.486;Q3;80;42;21;1801;47;20;2.24;42.88;United Kingdom;Western Europe;BMJ Publishing Group;2013-2021;"Cancer Research (Q3); Immunology (Q3); Immunology and Allergy (Q3); Molecular Medicine (Q3); Oncology (Q3); Pharmacology (Q3)"
354;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.486;Q1;61;117;380;4605;650;365;1.6;39.36;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
355;19900192163;Results in Pharma Sciences;journal;22112863;0.482;Q2;16;6;27;238;54;27;1.69;39.67;Netherlands;Western Europe;Elsevier BV;2011-2016;Pharmaceutical Science (Q2)
356;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.478;Q2;95;180;703;4938;1060;703;1.34;27.43;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
357;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.478;Q2;85;186;733;5203;944;732;1.3;27.97;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q2); Biochemistry (Q3); Catalysis (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
358;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.477;Q3;62;108;327;4271;528;327;1.53;39.55;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
359;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.475;Q3;66;96;270;3538;449;250;1.33;36.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q2); Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Organic Chemistry (Q3)"
360;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.471;Q3;69;143;379;3824;491;358;1.37;26.74;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
361;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.469;Q2;36;20;62;1585;93;56;1.16;79.25;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
362;17500155003;Records of Natural Products;journal;13076167;0.469;Q3;33;61;158;1453;239;158;1.17;23.82;Turkey;Middle East;ACG Publications;2009-2022;"Plant Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
363;19700174941;Pharmacognosy Research (discontinued);journal;09748490;0.467;Q3;37;57;139;1649;225;132;1.4;28.93;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2019, 2021;"Drug Discovery (Q3); Pharmacology (Q3)"
364;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.463;Q2;26;71;68;1510;86;60;1.26;21.27;United States;Northern America;Wiley-Blackwell;2012-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
365;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.46;Q3;37;70;288;1066;313;166;1.12;15.23;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
366;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.456;Q1;27;22;85;9;135;85;1.67;0.41;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
367;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.455;Q1;48;187;424;5634;577;411;1.46;30.13;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q3)"
368;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.454;Q3;44;158;307;5538;467;301;1.62;35.05;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Biochemistry (Q3); Biophysics (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
369;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.453;Q3;63;144;342;3619;410;318;1.05;25.13;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
370;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.453;Q3;46;65;194;2553;285;192;1.4;39.28;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
371;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.452;Q3;47;30;96;1316;134;96;1.35;43.87;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
372;23412;Journal of AOAC International;journal;10603271;0.446;Q3;90;229;657;5836;841;644;1.23;25.48;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Environmental Chemistry (Q3); Pharmacology (Q3)"
373;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.442;Q3;62;73;209;3093;289;197;1.47;42.37;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
374;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.441;Q3;44;65;221;2412;321;221;1.92;37.11;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Biochemistry (Q3); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
375;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.439;Q2;46;59;213;1496;354;211;1.4;25.36;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
376;19700177128;Journal of Young Pharmacists (discontinued);journal;09751505, 09751483;0.437;Q1;30;38;149;670;173;131;1.13;17.63;India;Asiatic Region;EManuscript Services;2010-2018, 2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
377;19700174889;Drug Target Insights;journal;11773928;0.435;Q1;13;7;12;311;23;12;2.2;44.43;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
378;21717;Die Pharmazie;journal;00317144;0.433;Q2;66;169;519;4656;695;519;1.25;27.55;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
379;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.431;Q3;29;27;68;1907;114;65;1.76;70.63;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Immunology and Allergy (Q3)"
380;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.427;Q3;53;62;217;2197;329;213;1.56;35.44;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
381;21100238633;BioImpacts;journal;22285652, 22285660;0.426;Q2;37;31;93;1236;166;85;1.81;39.87;Iran;Middle East;Tabriz University of Medical Sciences;2011-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
382;19700174904;Asian Journal of Pharmaceutical and Clinical Research (discontinued);journal;09742441, 24553891;0.424;Q2;41;380;1053;9649;891;1052;0.86;25.39;India;Asiatic Region;Asian Journal of Pharmaceutical and Clinical Research;2009-2018, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
383;5800173386;Current Drug Safety;journal;15748863;0.424;Q3;37;35;159;1681;251;149;1.41;48.03;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q3)"
384;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.423;Q1;69;207;678;3821;949;573;1.32;18.46;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
385;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.42;Q3;39;40;114;1090;173;114;1.54;27.25;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
386;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.42;Q3;46;86;337;3856;488;329;1.33;44.84;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
387;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.415;Q3;50;54;138;2447;230;135;1.68;45.31;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Bioengineering (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
388;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.412;Q2;50;479;1298;16101;2054;1297;1.58;33.61;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
389;59665;Chinese Journal of Natural Medicines;journal;16723651;0.411;Q3;40;138;280;4327;395;280;1.52;31.36;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
390;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.411;Q3;28;13;77;288;109;73;1.18;22.15;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3); Pharmacology (medical) (Q3)"
391;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.41;Q3;52;39;152;1647;187;148;0.86;42.23;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4); Embryology (Q4)"
392;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.408;Q2;42;172;516;2955;577;516;1.08;17.18;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
393;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.408;Q3;50;68;310;2721;331;310;0.98;40.01;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
394;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.407;Q2;63;0;931;0;1340;931;2;0;Nigeria;Africa;Academic Journals;2009-2012;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
395;27210;In Vivo;journal;17917549, 0258851X;0.406;Q3;64;169;410;4676;500;410;1.12;27.67;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
396;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.405;Q3;32;53;145;1579;149;144;0.93;29.79;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
397;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.402;Q2;60;40;120;1080;182;120;1.21;27;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
398;25864;Heterocycles;journal;03855414;0.398;Q3;66;269;724;10786;816;724;1.17;40.1;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
399;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.397;Q2;42;97;334;2278;430;280;0.97;23.48;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q3)"
400;18800156720;Dissolution Technologies;journal;1521298X;0.395;Q2;34;32;92;580;109;76;0.65;18.13;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
401;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.392;Q3;39;51;280;2757;285;277;0.96;54.06;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q3)
402;4500151530;Personalized Medicine;journal;17410541;0.389;Q3;33;78;272;3908;308;231;1.04;50.1;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
403;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.387;Q2;33;51;79;1763;123;79;1.64;34.57;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
404;130031;Journal of Toxicologic Pathology;journal;09149198;0.382;Q3;30;32;127;1176;112;125;0.71;36.75;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
405;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;0.38;Q2;15;51;164;1076;68;141;0.44;21.1;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Business and International Management (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Decision Sciences (miscellaneous) (Q3)"
406;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.38;Q3;31;36;113;1849;172;101;1.21;51.36;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
407;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.38;Q2;38;47;189;1569;233;189;1.14;33.38;China;Asiatic Region;Xi'an Jiaotong University;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Electrochemistry (Q3); Spectroscopy (Q3)"
408;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.379;Q3;62;149;568;2719;667;455;1.04;18.25;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
409;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.374;Q3;5;0;10;0;14;10;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2012;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
410;144963;Drug Discovery Today: Disease Models;journal;17406757;0.373;Q3;28;26;91;1240;64;80;0.42;47.69;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q3); Molecular Medicine (Q4)"
411;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.372;Q3;48;114;319;3812;330;314;1.13;33.44;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
412;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.371;Q3;50;461;1308;10886;1405;1283;1.06;23.61;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
413;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.369;Q3;26;103;152;2704;182;152;1.22;26.25;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology (Q3)
414;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.369;Q3;33;56;173;1811;226;172;1.36;32.34;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
415;21100318814;Pharmaceutical patent analyst;journal;20468954, 20468962;0.368;Q2;17;58;75;388;44;44;0.59;6.69;United Kingdom;Western Europe;Future Science;2012-2018, 2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
416;21100469670;Antibiotics;journal;20796382;0.365;Q2;47;41;37;2586;53;36;1.43;63.07;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010, 2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Infectious Diseases (Q3); Microbiology (Q3); Microbiology (medical) (Q3); Pharmacology (medical) (Q3)"
417;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.363;Q2;42;309;409;7177;454;409;0.97;23.23;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q2)
418;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.359;Q3;14;24;77;751;56;70;0.7;31.29;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q3); Drug Discovery (Q3)"
419;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.354;Q3;37;41;185;1686;230;176;1.2;41.12;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
420;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.352;Q2;35;169;528;2557;413;299;0.74;15.13;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
421;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.35;Q2;45;131;430;3756;498;429;1.01;28.67;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
422;4700152612;Current Nanoscience;journal;15734137;0.35;Q2;47;136;396;3897;496;387;1.18;28.65;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Nanoscience and Nanotechnology (Q3)"
423;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.348;Q2;61;87;346;2341;348;343;0.87;26.91;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
424;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;0.348;Q2;23;50;150;1872;176;150;1.36;37.44;Germany;Western Europe;Springer Verlag;2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
425;35190;Revista Espanola de Quimioterapia;journal;02143429;0.346;Q3;26;46;158;1279;153;117;0.86;27.8;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
426;144879;Toxicology International;journal;09716580;0.342;Q3;28;60;135;1606;160;131;1.12;26.77;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
427;21100219314;Applied and Translational Genomics;journal;22120661;0.341;Q2;21;33;21;600;12;18;0.57;18.18;Netherlands;Western Europe;Elsevier BV;2012-2016;"Pharmaceutical Science (Q2); Biotechnology (Q3); Molecular Biology (Q4)"
428;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.341;Q2;29;46;44;2307;43;43;0.98;50.15;Egypt;Africa/Middle East;Hindawi Limited;2013-2021;"Pharmaceutical Science (Q2); Biochemistry (Q3); Genetics (Q4); Molecular Biology (Q4)"
429;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.34;Q3;29;0;72;0;67;65;0.61;0;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
430;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.34;Q2;20;12;30;359;31;30;1.06;29.92;India;Asiatic Region;International Journal of Applied Pharmaceutics;2011-2021;Pharmaceutical Science (Q2)
431;19300156901;Dose-Response;journal;15593258;0.339;Q3;41;41;126;2841;207;123;1.56;69.29;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
432;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.338;Q3;28;12;47;391;56;46;1.19;32.58;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
433;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.337;Q3;51;165;458;5189;445;457;0.78;31.45;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
434;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.334;Q3;15;7;22;1014;31;0;1;144.86;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
435;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.332;Q3;29;141;276;4566;155;271;0.47;32.38;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
436;19900193266;International Journal of Ayurveda Research;journal;0974925X, 09747788;0.33;Q2;7;0;19;0;21;10;0;0;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011;Pharmaceutical Science (Q2)
437;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.329;Q3;30;55;226;3524;150;224;0.61;64.07;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
438;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;0.329;Q2;39;2088;2087;30851;1862;2087;0.88;14.78;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science (Q2)
439;19700174961;BioProcess International;trade journal;15426319;0.328;Q3;23;159;452;947;214;427;0.49;5.96;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
440;16836;BMC Chemical Biology;journal;14726769;0.328;Q3;20;0;7;0;9;7;1.8;0;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q3); Molecular Medicine (Q4)"
441;19700200880;Botulinum Journal;journal;17547326, 17547318;0.327;Q2;6;0;21;0;16;19;0.5;0;Switzerland;Western Europe;Inderscience Publishers;2009-2013, 2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Cellular and Molecular Neuroscience (Q4)"
442;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.325;Q3;29;44;137;843;112;112;0.72;19.16;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
443;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.325;Q2;16;24;42;892;30;31;0.86;37.17;United States;Northern America;IPEC-Americas;2010-2021;"Pharmaceutical Science (Q2); Food Science (Q3)"
444;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.323;Q3;38;62;124;2334;128;123;0.96;37.65;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
445;19700174969;Archives of Drug Information;journal;17535174;0.32;Q2;11;0;4;0;8;4;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2008-2011;"Complementary and Alternative Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
446;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.32;Q3;24;0;23;0;39;23;0;0;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q3)
447;19700175858;Journal of Pharmacognosy and Phytotherapy (discontinued);journal;21412502;0.318;Q3;22;11;66;404;51;66;0.53;36.73;United States;Northern America;Academic Journals Inc.;2010-2017;Drug Discovery (Q3)
448;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences (discontinued);journal;09751491;0.316;Q2;49;1543;2770;41650;1990;2770;0.64;26.99;India;Asiatic Region;IJPPS;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
449;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.315;Q2;50;87;476;3758;558;463;1.14;43.2;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
450;21496;Revista de Chimie (discontinued);journal;00347752;0.314;-;31;306;787;7420;583;787;0.82;24.25;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
451;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.312;Q3;17;34;104;1137;101;104;1.07;33.44;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
452;21192;Drug Development Research;journal;02724391, 10982299;0.311;Q3;62;76;210;2547;182;208;0.89;33.51;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
453;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.307;Q2;31;50;95;1586;79;94;0.83;31.72;Netherlands;Western Europe;Springer Netherlands;2012-2021;"Pharmaceutical Science (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
454;145693;Canadian Pharmacists Journal;journal;17151635;0.306;Q2;24;56;316;880;95;140;0.32;15.71;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
455;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.306;Q2;28;17;92;483;96;90;0.89;28.41;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Pharmaceutical Science (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
456;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.305;Q3;36;56;98;2254;94;96;1.19;40.25;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
457;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.305;Q2;31;32;72;1092;79;70;1.17;34.13;United States;Northern America;Springer New York;2006-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
458;19700175060;International Journal of PharmTech Research (discontinued);journal;09744304;0.304;Q2;48;279;789;6705;597;789;0.57;24.03;India;Asiatic Region;Sphinx Knowledge House;2009-2016;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
459;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.303;Q2;23;18;50;507;56;50;1;28.17;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
460;21100241608;Journal of Nanomedicine and Nanotechnology (discontinued);journal;21577439;0.302;Q2;24;18;117;725;131;87;1.18;40.28;United States;Northern America;OMICS Publishing Group;2010-2014;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
461;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.3;Q3;64;35;118;1014;105;98;1.05;28.97;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
462;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.299;Q2;25;14;50;521;43;50;0.55;37.21;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q4)"
463;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.298;Q2;57;59;177;2000;190;174;1.09;33.9;United States;Northern America;Informa Healthcare;2013-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
464;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.298;Q3;48;42;112;1200;71;102;0.68;28.57;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4)"
465;19500156813;Procedia in Vaccinology;journal;1877282X;0.298;Q2;15;0;64;0;41;64;0.62;0;Netherlands;Western Europe;Elsevier;2009-2012;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Immunology (Q4)"
466;17700155411;Research Journal of Environmental Toxicology (discontinued);journal;18193420;0.297;Q3;18;11;64;422;74;64;0.48;38.36;United States;Northern America;Academic Journals Inc.;2009-2016;"Pollution (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
467;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;0.296;Q2;48;49;124;1976;114;122;1.01;40.33;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
468;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.296;Q4;32;75;205;1668;232;201;1.25;22.24;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
469;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.295;Q3;21;2;22;56;14;22;0.57;28;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
470;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.295;Q2;51;224;639;5583;517;636;0.69;24.92;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Biochemistry (Q4)"
471;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.293;Q4;61;65;209;1399;172;157;0.76;21.52;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
472;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0.292;Q2;33;0;408;0;365;408;0;0;Nigeria;Africa;Academic Journals;2009-2011;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
473;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.292;Q2;22;59;173;1249;155;173;0.51;21.17;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
474;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.291;Q2;42;90;134;2782;164;134;1.28;30.91;Iran;Middle East;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
475;21100199811;Stamford Journal of Pharmaceutical Sciences;journal;19997108;0.286;Q2;9;0;26;0;20;26;0;0;Bangladesh;Asiatic Region;Department of Pharmacy, Stamford University Bangladesh;2011;Pharmaceutical Science (Q2)
476;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.284;Q2;28;37;101;1112;76;99;0.86;30.05;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
477;19700200724;Der Pharmacia Lettre (discontinued);journal;09755071;0.283;Q2;28;280;807;6038;464;807;0.51;21.56;India;Asiatic Region;Scholars Research Library;2011-2016;Pharmaceutical Science (Q2)
478;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.282;Q2;17;23;91;935;74;78;0.85;40.65;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuroscience (miscellaneous) (Q3); Neuropsychology and Physiological Psychology (Q4)"
479;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.281;Q2;41;249;1117;7263;736;1115;0.54;29.17;India;Asiatic Region;MediPoeia;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
480;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;0.281;Q3;27;271;772;6676;421;771;0.59;24.63;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Chemistry (miscellaneous) (Q3); Drug Discovery (Q3); Biochemistry (Q4); Environmental Chemistry (Q4)"
481;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0.28;Q2;11;0;66;0;50;66;0.76;0;India;Asiatic Region;R R College of Pharmacy;2010, 2012-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
482;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.274;Q3;24;24;100;910;91;88;1.31;37.92;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4)"
483;19700175758;International Journal of Drug Development and Research (discontinued);journal;09759344;0.274;Q2;24;103;540;2618;295;538;0.45;25.42;India;Asiatic Region;International Journal of Drug Development and Research;2010-2015;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
484;19700174900;International Journal of Green Pharmacy (discontinued);journal;19984103, 09738258;0.274;Q3;26;44;180;1626;103;177;0.53;36.95;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
485;19700188355;International Journal of Phytomedicine (discontinued);journal;09750185;0.27;Q3;20;66;206;2118;127;206;0.28;32.09;United States;Northern America;Advanced Research Journals;2010-2016;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
486;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.266;Q4;32;55;145;1779;124;134;0.8;32.35;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Parasitology (Q4); Toxicology (Q4)"
487;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;0.264;Q2;18;12;113;416;80;113;0.35;34.67;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
488;21100470510;Drug Research;journal;21949379, 21949387;0.262;Q3;65;180;395;4342;304;388;0.79;24.12;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
489;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.262;Q4;12;107;323;1499;31;323;0.09;14.01;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q2); Pathology and Forensic Medicine (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
490;21100825823;Pharmacology Research and Perspectives;journal;20521707;0.262;Q2;32;54;16;2164;14;16;0.88;40.07;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (Q3)"
491;20400195018;International Journal of Pharmacognosy and Phytochemical Research (discontinued);journal;09754873;0.261;Q3;19;190;120;4938;57;120;0.36;25.99;India;Asiatic Region;International Journal of Pharmacognosy and Phytochemical Research;2011-2016, 2020;Drug Discovery (Q3)
492;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.26;Q3;39;292;383;6133;345;381;0.81;21;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
493;21810;Farmacia;journal;00148237;0.259;Q2;27;100;325;2221;255;324;0.84;22.21;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
494;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.256;Q3;13;31;80;563;37;79;0.49;18.16;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
495;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.256;Q4;48;9;137;508;93;122;0.73;56.44;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
496;73430;Pharmaceutical Technology;journal;15432521;0.255;Q3;38;167;612;530;85;553;0.16;3.17;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q3); Biophysics (Q4)"
497;19700175096;Pharmacognosy Journal;journal;09753575;0.255;Q3;25;101;280;2929;175;273;0.66;29;India;Asiatic Region;EManuscript Technologies;2009-2021;"Drug Discovery (Q3); Pharmacology (Q3)"
498;20578;Journal of Food and Drug Analysis;journal;10219498;0.253;Q3;63;67;300;2982;208;295;0.65;44.51;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
499;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.251;Q3;52;105;211;3996;153;204;0.54;38.06;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q3)
500;21100196907;Open Toxinology Journal;journal;18754147;0.25;Q4;2;0;2;0;4;2;0;0;Netherlands;Western Europe;;;"Pharmacology (medical) (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
501;130089;Toxin Reviews;journal;15569543, 15569551;0.249;Q4;46;28;30;1686;30;29;0.76;60.21;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q4)
502;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.247;Q2;33;35;68;1696;122;66;1.61;48.46;Spain;Western Europe;Elsevier Espana;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
503;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.246;Q3;48;167;349;2055;388;346;0.85;12.31;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
504;5800173401;Current Bioactive Compounds;journal;15734072;0.246;Q2;27;29;103;1736;84;91;0.64;59.86;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
505;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.246;Q3;19;21;62;453;53;57;0.62;21.57;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
506;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;0.245;Q3;8;0;18;0;12;18;0.43;0;Switzerland;Western Europe;Inderscience Publishers;2011;"Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
507;80593;Journal of Medicinal Plants;journal;16840240;0.245;Q3;23;55;214;1689;99;214;0.39;30.71;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
508;17700156303;Neuromethods;book series;19406045, 08932336;0.244;Q2;21;141;562;7866;208;490;0.31;55.79;United States;Northern America;Humana Press;2009-2022;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Neuroscience (miscellaneous) (Q4)"
509;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.243;Q3;25;36;129;1263;102;127;0.82;35.08;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
510;19700170617;EXCLI Journal;journal;16112156;0.242;Q3;43;109;220;6120;244;188;1.14;56.15;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Drug Discovery (Q3); Pharmacology (Q3); Animal Science and Zoology (Q4); Molecular Medicine (Q4)"
511;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.241;-;31;87;173;2174;134;147;0.79;24.99;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
512;130038;Letters in Drug Design and Discovery;journal;15701808;0.241;Q3;35;135;393;4348;303;388;0.85;32.21;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
513;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.238;Q3;27;49;141;1641;113;124;0.71;33.49;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
514;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.237;Q2;23;117;185;2337;88;171;0.42;19.97;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
515;19700188484;Journal of Bioequivalence and Bioavailability (discontinued);journal;09750851;0.237;Q3;12;30;148;993;61;120;0.36;33.1;United States;Northern America;OMICS Publishing Group;2011-2014;Pharmaceutical Science (Q3)
516;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;0.235;Q2;21;50;271;1114;110;271;0.38;22.28;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
517;19700188309;Journal of Bioanalysis and Biomedicine (discontinued);journal;1948593X;0.235;Q3;11;3;80;66;47;59;0.32;22;United States;Northern America;OMICS Publishing Group;2010-2014;Pharmaceutical Science (Q3)
518;23489;Chemical Speciation and Bioavailability;journal;09542299;0.231;Q4;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
519;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.231;Q3;53;79;183;1757;117;161;0.61;22.24;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
520;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.231;Q2;16;34;106;1011;66;95;0.66;29.74;United Kingdom;Western Europe;Oxford University Press;2010-2021;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
521;19700201609;Open Natural Products Journal;journal;18748481;0.231;Q3;3;1;9;67;9;9;0.83;67;Netherlands;Western Europe;;;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3)"
522;19446;American Pharmaceutical Review;journal;10998012;0.23;Q3;24;71;225;900;92;211;0.39;12.68;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
523;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.227;Q3;27;72;533;2273;239;532;0.28;31.57;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Drug Discovery (Q3); Pharmacology (Q3)"
524;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.226;Q2;48;115;348;3366;234;347;0.53;29.27;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
525;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;1943085X, 19430906;0.226;Q3;15;0;93;0;67;93;0.7;0;United States;Northern America;Taylor and Francis Ltd.;2009-2012;"Biomedical Engineering (Q3); Pharmaceutical Science (Q3); Nanoscience and Nanotechnology (Q4)"
526;15500154707;International Journal of Biological Chemistry (discontinued);journal;21522561, 1819155X;0.225;Q3;16;7;62;416;59;60;0.5;59.43;Pakistan;Asiatic Region;Asian Network for Scientific Information;2009-2016;"Pharmacology (Q3); Biochemistry (Q4)"
527;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.225;Q4;7;26;85;349;14;76;0.11;13.42;India;Asiatic Region;Punjab Academy of Forensic Medicine and Toxicology;2011-2020;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
528;21758;Prescrire International;journal;11677422;0.225;Q3;13;186;620;1270;130;576;0.21;6.83;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
529;15340;Developments in Biologicals;journal;14246074, 16622960;0.224;Q3;38;0;42;0;22;41;0.52;0;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
530;19200156925;Cancer Therapy;journal;15439143, 15439135;0.221;Q3;8;4;14;408;19;14;0.18;102;United States;Northern America;Gene Therapy Press;2009-2014;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
531;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.22;Q3;19;16;109;867;81;86;0.59;54.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
532;23171;Korean Journal of Pharmacognosy;journal;02533073;0.22;Q3;17;55;92;1442;54;92;0.59;26.22;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3)"
533;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.22;Q2;24;67;279;1235;105;278;0.22;18.43;India;Asiatic Region;Rasayan Journal;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
534;19700201333;International Journal of Drug Delivery (discontinued);journal;09750215;0.219;Q3;15;40;129;1284;76;129;0.2;32.1;United States;Northern America;Advanced Research Journals;2011-2015;Pharmaceutical Science (Q3)
535;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.219;Q3;34;167;469;2898;223;425;0.45;17.35;United States;Northern America;Springer New York;1967-2021;"Pharmacology (Q3); Drug Discovery (Q4)"
536;22881;Yaoxue Xuebao;journal;05134870;0.219;Q3;34;256;786;6678;476;786;0.62;26.09;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
537;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;0.217;Q3;30;90;253;2058;106;253;0.3;22.87;India;Asiatic Region;;2009-2018, 2020-2021;Pharmaceutical Science (Q3)
538;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.216;Q3;19;29;103;869;30;86;0.35;29.97;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
539;13718;Pharmaceutical Engineering;journal;02738139;0.216;Q3;16;66;174;529;27;151;0.15;8.02;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
540;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.215;Q3;42;41;77;1416;62;73;0.92;34.54;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
541;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.213;Q3;15;28;92;219;25;82;0.23;7.82;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
542;4700152607;Current Enzyme Inhibition;journal;15734080;0.212;Q4;18;16;55;683;27;49;0.43;42.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
543;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.212;Q3;29;35;101;998;65;101;0.53;28.51;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
544;21100244805;Journal of Vaccines and Vaccination (discontinued);journal;21577560;0.211;Q4;12;31;126;1090;40;105;0.31;35.16;United States;Northern America;OMICS Publishing Group;2010-2014;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
545;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.21;Q3;10;16;34;1045;24;34;0.29;65.31;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
546;19700188319;International Journal of Pharmaceutical Sciences Review and Research (discontinued);journal;0976044X;0.209;Q3;33;638;1214;19592;454;1213;0.29;30.71;India;Asiatic Region;Global Research Online;2010-2016, 2020-2021;Pharmaceutical Science (Q3)
547;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.206;Q3;14;18;94;683;42;88;0.34;37.94;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
548;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.203;Q3;22;56;186;1935;99;173;0.53;34.55;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3); Drug Discovery (Q4); Plant Science (Q4)"
549;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.203;Q3;24;86;303;1254;111;204;0.31;14.58;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
550;19700174931;Asian Journal of Pharmaceutics (discontinued);journal;1998409X, 09738398;0.202;Q3;23;37;101;1254;45;98;0.45;33.89;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
551;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.201;Q3;12;7;42;411;21;38;0.53;58.71;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
552;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.2;Q3;43;101;284;3459;144;274;0.4;34.25;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
553;25144;Journal of Health Science;journal;13475207, 13449702;0.2;Q4;49;0;70;0;52;63;0;0;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
554;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.199;Q3;13;113;234;2828;117;232;0.43;25.03;China;Asiatic Region;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-2021;Pharmaceutical Science (Q3)
555;110097;Food and Drug Law Journal;journal;1064590X;0.197;Q3;22;25;69;0;24;68;0.39;0;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q4)"
556;21265;Drugs of the Future;journal;03778282;0.196;Q3;45;119;332;2567;112;329;0.25;21.57;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
557;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.195;Q3;10;9;9;1155;5;8;0.5;128.33;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Pharmacology (Q3); Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4)"
558;19700174658;Regulatory Rapporteur;trade journal;17428955;0.195;Q3;6;74;214;449;21;174;0.08;6.07;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacy (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
559;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.194;Q3;7;9;35;450;6;35;0;50;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
560;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.194;Q3;19;270;686;1745;51;667;0.06;6.46;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
561;21100202909;Drug Invention Today (discontinued);journal;09757619;0.193;Q4;20;3;145;98;76;144;0.52;32.67;India;Asiatic Region;Association of Pharmaceutical Innovators;2012-2021;Drug Discovery (Q4)
562;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.193;Q3;21;70;106;2150;69;95;0.65;30.71;United States;Northern America;Elsevier USA;2012-2021;"Economics, Econometrics and Finance (miscellaneous) (Q3); Health Policy (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
563;19700170837;Vitae;journal;21452660, 01214004;0.193;Q3;15;82;134;1172;41;72;0.11;14.29;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Food Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4)"
564;58808;Pharmaceutical Care and Research;journal;16712838;0.192;Q3;8;166;468;1318;56;467;0.11;7.94;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
565;25197;Revista de Toxicologia (discontinued);journal;02127113;0.192;Q4;11;9;51;383;9;49;0.13;42.56;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
566;15600154705;EnvironmentAsia;journal;19061714;0.191;Q4;19;35;65;937;27;65;0.28;26.77;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
567;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.191;Q3;22;130;100;8468;52;100;0.52;65.14;United Kingdom;Western Europe;Taylor and Francis Ltd.;2013-2021;"Health Policy (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
568;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.191;Q3;9;68;158;1250;24;147;0.1;18.38;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
569;21100205709;International Journal of Toxicological and Pharmacological Research (discontinued);journal;09755160;0.19;Q3;10;28;46;678;16;46;0.4;24.21;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
570;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.19;Q3;9;43;100;1263;24;88;0.22;29.37;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
571;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.19;Q4;41;46;69;5657;48;2;0.7;122.98;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
572;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.189;Q3;9;45;93;463;13;69;0.11;10.29;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q4)"
573;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.189;Q3;43;184;473;3686;182;422;0.28;20.03;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
574;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.188;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
575;21798;Farmaceutski Glasnik;journal;00148202;0.188;Q3;6;81;209;723;9;172;0.05;8.93;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
576;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.188;Q3;16;39;100;1033;48;100;0.48;26.49;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
577;19408;Actualites Pharmaceutiques;journal;05153700;0.187;Q4;5;165;597;561;7;520;0.01;3.4;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
578;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.186;Q3;17;5;35;207;7;30;0.11;41.4;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
579;24071;Metal-Based Drugs;journal;07930291, 16875486;0.186;Q4;38;0;1;0;2;1;0;0;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q4); Inorganic Chemistry (Q4); Pharmacology (Q4); Toxicology (Q4)"
580;19700175040;Open Vaccine Journal;journal;18750354;0.183;Q3;9;0;10;0;8;8;0.5;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4)"
581;21100197929;Toxicological Research;journal;19768257, 22342753;0.183;Q4;35;39;152;1407;68;152;0.48;36.08;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
582;19700188326;American Journal of Drug Discovery and Development (discontinued);journal;2150427X, 21504296;0.182;Q4;12;22;67;782;38;67;0.41;35.55;United States;Northern America;Academic Journals Inc.;2011-2015;Drug Discovery (Q4)
583;21100293201;International Journal of Research in Ayurveda and Pharmacy (discontinued);journal;22774343, 22293566;0.179;Q3;13;118;397;2619;77;397;0.19;22.19;India;Asiatic Region;Moksha Publishing House;2012-2016;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
584;21100785531;International Journal of Medicinal and Aromatic Plants;journal;22494340;0.178;Q4;3;0;3;0;3;3;0.5;0;India;Asiatic Region;;;"Drug Discovery (Q4); Plant Science (Q4)"
585;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.174;Q3;20;0;37;0;16;37;0;0;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q3)
586;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.174;Q4;24;21;42;1038;21;40;0.5;49.43;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q4); Pharmacology (Q4)"
587;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.173;Q3;24;37;76;899;40;70;0.51;24.3;Netherlands;Western Europe;Kowsar Publishing Company;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
588;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.173;Q4;10;13;30;650;10;1;0.33;50;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q4); Organic Chemistry (Q4)"
589;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;0.173;Q3;28;3;31;58;17;30;0.21;19.33;India;Asiatic Region;EManuscript Technologies;2010-2021;Pharmaceutical Science (Q3)
590;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.172;Q3;21;10;36;877;28;0;0.72;87.7;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
591;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.172;Q4;14;51;151;1408;50;145;0.32;27.61;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
592;19700174940;SA Pharmaceutical Journal;journal;10151362;0.172;Q3;7;84;413;496;22;244;0.04;5.9;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science (Q3)
593;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.171;Q4;10;58;370;1105;48;370;0.1;19.05;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Medicine (miscellaneous) (Q3); Biochemistry (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
594;19700200860;International Journal of Current Pharmaceutical Review and Research (discontinued);journal;0976822X;0.171;Q3;14;11;45;235;20;45;0.27;21.36;India;Asiatic Region;Publishers, In-IJCPR;2010-2017;Pharmaceutical Science (Q3)
595;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.171;Q3;10;20;5;784;7;4;1.4;39.2;Chile;Latin America;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
596;19900192173;International Journal of Pharmaceutical and Clinical Research (discontinued);journal;09751556;0.169;Q3;13;64;63;1914;27;63;0.27;29.91;Australia;Pacific Region;International Journal of Pharmaceutical and Clinical Research;2011-2016;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
597;79053;Natural Product Sciences;journal;12263907;0.168;Q4;28;52;163;1232;48;163;0.19;23.69;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
598;19700201471;International Journal of Pharmacy and Technology (discontinued);journal;0975766X;0.167;Q3;23;81;494;1904;118;493;0.2;23.51;India;Asiatic Region;International Journal of Pharmacy and Technology(IJPT);2011-2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
599;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.167;Q3;10;63;45;2288;10;42;0.22;36.32;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
600;21100451405;Natural Products Journal;journal;22103163, 22103155;0.167;Q4;13;40;97;1595;42;92;0.46;39.88;Netherlands;Western Europe;Bentham Science Publishers B.V.;2011-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
601;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.167;Q3;32;918;2397;8941;728;2396;0.28;9.74;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
602;21100195303;Eurasian Journal of Analytical Chemistry (discontinued);journal;13063057;0.166;Q3;16;9;50;264;22;50;0.17;29.33;Turkey;Middle East;Moment Publications;2010-2018, 2020;"Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Electrochemistry (Q4); Spectroscopy (Q4)"
603;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.165;Q4;14;37;31;1001;17;31;0.55;27.05;Italy;Western Europe;ASLERD;2012-2021;"Architecture (Q2); Media Technology (Q2); Social Sciences (miscellaneous) (Q3); Computer Science Applications (Q4); Human-Computer Interaction (Q4); Pharmacology (Q4)"
604;9800153137;Trastornos Adictivos;journal;15750973;0.165;Q4;9;0;45;0;11;37;0.26;0;Spain;Western Europe;Ediciones Doyma, S.L.;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
605;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.164;Q4;16;54;126;4628;32;116;0.28;85.7;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
606;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.164;Q4;22;27;68;834;30;68;0.56;30.89;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
607;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences (discontinued);journal;09758585;0.164;Q3;31;1228;1705;26959;438;1705;0.22;21.95;India;Asiatic Region;RJPBCS;2010-2017, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
608;20065;BioPharm International;trade journal;1542166X, 19391862;0.162;Q3;29;97;389;320;65;361;0.12;3.3;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
609;22934;Chinese Pharmaceutical Journal;journal;10012494;0.162;Q3;21;448;1429;7052;313;1429;0.2;15.74;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
610;19700175149;African Journal Biomedical Research;journal;11195096;0.161;Q3;17;28;92;760;27;91;0.16;27.14;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
611;4700152278;Drugs in Context;journal;17404398, 17451981;0.161;Q4;26;7;16;361;15;14;0.94;51.57;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
612;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.16;Q4;21;8;35;198;13;35;0.32;24.75;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q4)
613;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.159;Q3;14;47;148;1596;54;148;0.28;33.96;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Pharmaceutical Science (Q3); Biotechnology (Q4); Drug Discovery (Q4)"
614;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.159;Q3;4;56;157;978;5;145;0.02;17.46;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
615;21100265336;International Arabic Journal of Antimicrobial Agents (discontinued);journal;21749094;0.159;Q4;8;12;40;483;15;39;0.38;40.25;Spain;Western Europe;Internet Medical Publishing;2011-2015;"Pharmacology (medical) (Q3); Microbiology (medical) (Q4); Pharmacology (Q4)"
616;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.159;Q3;10;3;54;117;29;54;0.35;39;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2012, 2014-2021;Pharmaceutical Science (Q3)
617;22908;Chinese Pharmacological Bulletin;journal;10011978;0.157;Q4;17;397;1276;6663;403;1276;0.32;16.78;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
618;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.157;Q3;46;100;410;2003;140;355;0.33;20.03;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4)"
619;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.156;Q4;20;97;414;619;130;273;0.4;6.38;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
620;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.155;Q3;21;21;66;775;30;66;0.55;36.9;United States;Northern America;Science Publications;2007-2016;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
621;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.155;Q3;10;19;70;570;22;70;0.23;30;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science (Q3)
622;19900193894;Open Pharmacoeconomics and Health Economics Journal;journal;18768245;0.155;Q3;3;0;8;0;3;8;0.33;0;Netherlands;Western Europe;;;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
623;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.155;Q3;47;255;955;6399;142;955;0.18;25.09;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
624;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.154;Q3;8;9;38;344;11;38;0.17;38.22;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
625;5800173394;Current Drug Therapy;journal;15748855;0.154;Q3;17;23;90;1402;40;85;0.32;60.96;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
626;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.152;Q3;10;4;79;348;27;79;0.49;87;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q4)"
627;21100804474;European Pharmaceutical Journal;journal;24536725;0.151;Q3;8;12;61;320;12;60;0.22;26.67;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
628;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.151;Q3;0;0;0;0;0;0;0;0;Turkey;Middle East;Marmara University;2010-2019;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
629;21100301603;National Journal of Physiology, Pharmacy and Pharmacology (discontinued);journal;23204672, 22313206;0.15;Q3;13;63;79;1091;22;70;0.29;17.32;India;Asiatic Region;Mrs Dipika Charan for MedScience Publishers;2011-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Physiology (Q4)"
630;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.15;Q4;9;35;85;770;27;78;0.37;22;France;Western Europe;Elsevier Masson s.r.l.;2014-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
631;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.149;Q3;18;87;206;3111;63;206;0.28;35.76;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
632;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.148;Q4;11;19;134;488;25;128;0.17;25.68;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
633;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.148;Q3;6;13;37;249;8;34;0.42;19.15;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
634;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;0.148;Q3;3;0;12;0;4;11;0.5;0;New Zealand;Pacific Region;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
635;19700181241;Physiology and Pharmacology;journal;17350581;0.148;Q4;12;45;147;1654;38;145;0.3;36.76;Iran;Middle East;Neuroscience Research Center;2009-2021;"Pharmacology (Q4); Physiology (Q4)"
636;19700171709;Arhiv za Farmaciju;journal;00041963;0.147;Q3;4;36;101;710;6;100;0.07;19.72;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
637;19900194805;Genomic Medicine, Biomarkers, and Health Sciences;journal;22114254, 22114262;0.146;Q4;7;0;53;0;16;52;0.26;0;Taiwan;Asiatic Region;Elsevier Taiwan LLC;2011-2012;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
638;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;0.146;Q3;17;6;96;114;23;96;0.17;19;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science (Q3)
639;21100237602;Journal of Pharmacy and Nutrition Sciences (discontinued);journal;19275951, 22233806;0.146;Q4;12;34;81;964;25;81;0.22;28.35;Canada;Northern America;;2011-2021;"Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
640;19700201410;Milestones in Drug Therapy;book series;22966056;0.146;Q3;5;1;98;23;15;93;0.19;23;United States;Northern America;Springer Science + Business Media;2010-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4)"
641;5200152604;Pharma Times;journal;00316849;0.146;Q4;12;83;231;546;27;146;0.1;6.58;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
642;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.145;Q3;10;37;96;164;9;92;0.12;4.43;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
643;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.144;Q3;11;97;243;280;16;131;0.08;2.89;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science (Q3)
644;73076;Drug Discovery World;journal;14694344;0.144;Q4;13;39;124;385;30;111;0.17;9.87;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
645;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277, 09644679;0.143;Q4;6;13;70;142;16;55;0.22;10.92;United Kingdom;Western Europe;Pharmaceutical and Healthcare Sciences Society;2010-2016, 2018-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4)"
646;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.142;Q4;15;106;364;1160;62;363;0.15;10.94;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
647;19700201516;Journal of Chemical and Pharmaceutical Sciences (discontinued);journal;09742115;0.142;Q4;25;167;116;1864;19;116;0.19;11.16;India;Asiatic Region;SPB Pharma Society;2010-2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
648;20564;Ceska a Slovenska Farmacie;journal;12107816;0.14;Q4;17;39;127;1191;29;121;0.23;30.54;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q4)
649;21100248874;Dilemas;journal;19835922, 21782792;0.14;-;9;32;24;900;6;24;0.25;28.13;Brazil;Latin America;Universidade Federal do Rio de Janeiro - UFRJ;2013-2021;"Law (Q3); Sociology and Political Science (Q3)"
650;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.14;Q4;5;16;90;584;5;87;0.08;36.5;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
651;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.14;Q4;7;3;11;80;2;10;0.33;26.67;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
652;21211;Pharmacy Education;journal;14772701, 15602214;0.139;Q4;18;22;68;453;15;68;0.31;20.59;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q3); Education (Q4); Pharmaceutical Science (Q4)"
653;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.138;Q4;9;22;42;641;11;41;0.26;29.14;Iran;Middle East;Wolters Kluwer Medknow Publications;2012-2021;"Biomedical Engineering (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
654;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.137;Q4;14;20;53;69;11;53;0.16;3.45;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
655;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.135;Q4;17;655;1757;9826;323;1606;0.17;15;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
656;22338;Hospital Pharmacy;journal;19451253, 00185787;0.135;Q4;24;157;421;2786;71;377;0.2;17.75;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
657;19700175049;Internet Journal of Toxicology;journal;15593916;0.135;Q4;7;0;9;0;3;9;0.17;0;United States;Northern America;Internet Scientific Publications, LLC;2009-2011, 2013, 2015;Toxicology (Q4)
658;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.135;Q4;12;0;59;0;14;59;0.16;0;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
659;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.135;Q4;10;45;130;1134;23;130;0.16;25.2;Netherlands;Western Europe;IOS Press BV;2010-2021;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
660;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.134;Q4;14;18;47;371;9;46;0.14;20.61;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
661;21100228007;Archives of Razi Institute;journal;20089872, 03653439;0.134;Q4;10;28;48;757;14;48;0.29;27.04;Iran;Middle East;Razi Vaccine and Serum Research Institute;2012-2021;"Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
662;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.133;Q4;19;26;81;761;19;81;0.2;29.27;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
663;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.133;Q4;13;49;170;811;8;127;0.06;16.55;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
664;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.132;Q4;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
665;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;0.132;Q4;10;9;26;325;14;26;0.42;36.11;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
666;15842;Journal of Applied Research;journal;1537064X;0.131;Q4;22;4;26;102;11;26;0.47;25.5;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
667;22375;Indian Drugs;journal;0019462X;0.13;Q4;31;73;262;1808;31;262;0.11;24.77;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
668;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.13;Q4;13;39;80;903;19;79;0.19;23.15;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2021;"Bioengineering (Q4); Pharmaceutical Science (Q4)"
669;22514;Japanese Journal of Chemotherapy;journal;13407007;0.13;Q4;12;19;85;384;14;85;0.09;20.21;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
670;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;0.13;Q4;9;0;9;0;3;8;0;0;India;Asiatic Region;;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
671;21127;Pharmaceutical Technology Europe;journal;01646826;0.129;Q4;18;153;250;696;10;178;0.02;4.55;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q4)
672;130170;Phytotherapie;journal;17652847, 16248597;0.129;Q4;18;71;221;1680;24;151;0.06;23.66;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
673;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.128;Q4;10;21;61;573;17;55;0.24;27.29;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
674;19700201509;Pharma Research (discontinued);journal;09758216;0.128;Q4;5;17;100;315;15;99;0.09;18.53;India;Asiatic Region;Sudarshan Publications;2011-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
675;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.127;Q4;7;4;13;68;2;13;0.18;17;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011, 2013-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
676;20543;Pharmacometrics;journal;03008533;0.127;Q4;6;0;30;0;8;30;0.29;0;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
677;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.126;Q4;7;28;89;503;5;82;0;17.96;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q4)
678;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;0.126;Q4;9;6;39;200;13;39;0.26;33.33;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
679;19700194018;Russian Journal of Biopharmaceuticals (discontinued);journal;20738099;0.126;Q4;6;43;101;531;10;100;0.11;12.35;Russian Federation;Eastern Europe;Folium Publishing Company;2011-2021;"Bioengineering (Q4); Drug Discovery (Q4)"
680;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.125;Q4;4;29;65;443;5;44;0.11;15.28;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
681;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.124;Q4;17;31;122;630;26;104;0.1;20.32;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Cardiology and Cardiovascular Medicine (Q4); Critical Care and Intensive Care Medicine (Q4); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
682;25253;Blutalkohol (discontinued);journal;00065250;0.124;Q4;13;32;85;409;6;83;0.07;12.78;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
683;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.124;-;12;53;132;1326;12;132;0.08;25.02;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
684;22906;Journal of China Pharmaceutical University;journal;10005048;0.124;Q4;14;125;307;2573;48;307;0.18;20.58;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
685;21100782803;Current Psychopharmacology;journal;22115560, 22115579;0.123;Q4;4;0;1;0;0;1;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2012, 2015-2016;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
686;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;0.123;Q4;1;1;1;13;0;1;0;13;India;Asiatic Region;;2012, 2014, 2016;"Applied Microbiology and Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
687;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;0.123;Q4;1;0;1;0;0;1;0;0;India;Asiatic Region;;2012, 2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
688;21716;Pharmazeutische Zeitung;journal;00317136;0.123;Q4;7;685;1852;855;10;1071;0;1.25;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
689;21100784233;Proceedings of the 2013 21st Euromicro International Conference on Parallel, Distributed, and Network-Based Processing, PDP 2013;conference and proceedings;-;0.123;-;0;0;1;0;0;1;0;0;United States;Northern America;;;"Pharmaceutical Science; Statistics and Probability"
690;21100335701;Vaccines;journal;2076393X;0.123;Q4;50;42;2;3639;0;1;0;86.64;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2013-2021;"Drug Discovery (Q4); Immunology (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
691;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.122;Q4;16;92;245;1285;26;245;0.09;13.97;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
692;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.121;Q4;12;142;410;3394;51;410;0.13;23.9;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
693;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.121;Q4;9;0;18;0;1;18;0;0;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
694;24097;Journal of the Indian Chemical Society;journal;00194522;0.121;Q4;33;286;764;8517;165;757;0.2;29.78;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
695;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.121;Q4;6;54;139;190;9;108;0.08;3.52;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q4)
696;21142;Pharmaceutisch Weekblad;journal;00316911;0.12;Q4;9;384;1235;780;12;941;0.01;2.03;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
697;21100208082;VacciMonitor;journal;10250298, 1025028X;0.12;Q4;5;19;46;341;8;44;0.17;17.95;Cuba;Latin America;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-2021;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
698;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.119;Q4;11;10;41;123;4;20;0.09;12.3;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
699;9100153105;Current Topics in Pharmacology;journal;09724559;0.118;Q4;6;11;40;681;6;40;0.11;61.91;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
700;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.118;Q4;11;79;286;0;40;275;0.23;0;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q3); Pharmacy (Q3); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
701;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.118;Q4;19;9;55;194;5;44;0.11;21.56;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Drug Guides (Q3); Pharmacy (Q3); Pharmacology (Q4)"
702;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.118;Q4;5;10;29;627;5;24;0.17;62.7;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
703;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.117;Q4;20;44;71;637;7;69;0.02;14.48;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
704;13000154717;Current Topics in Toxicology;journal;09728228;0.117;Q4;7;11;22;426;7;22;0.11;38.73;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
705;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.117;Q4;12;28;183;811;24;181;0.1;28.96;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
706;19700201404;Open Drug Safety Journal;journal;18768180;0.116;Q4;3;0;11;0;5;11;0;0;Netherlands;Western Europe;;;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
707;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.115;Q4;19;114;313;2018;30;281;0.1;17.7;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
708;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;0.115;Q4;24;60;209;1565;30;207;0.08;26.08;India;Asiatic Region;Advanced Scientific Research;2010-2021;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
709;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.114;Q4;6;15;42;552;8;41;0.17;36.8;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
710;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;20660170, 15830012;0.114;Q4;3;29;102;504;11;100;0.05;17.38;Romania;Eastern Europe;Rp Publishing House;2011-2012, 2014-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
711;19700175039;Open Toxicology Journal;journal;18743404;0.113;Q4;8;0;8;0;1;7;0.13;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2010, 2012-2013;Toxicology (Q4)
712;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.113;Q4;6;42;114;211;8;103;0.08;5.02;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
713;22358;U.S. Pharmacist;trade journal;01484818;0.113;Q4;9;160;467;2380;31;386;0.06;14.88;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
714;19700174925;European Pharmaceutical Review;trade journal;13608606;0.112;Q4;8;54;143;883;15;143;0.07;16.35;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
715;5200152843;Farmaceutico Hospitales;journal;02144697;0.112;Q4;3;0;21;0;1;13;0;0;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
716;19700188318;International Journal of Advances in Pharmaceutical Sciences (discontinued);journal;09761055;0.112;Q4;11;0;6;0;2;6;0;0;United States;Northern America;Advanced Research Journals;2010-2011;"Pharmaceutical Science (Q4); Physical and Theoretical Chemistry (Q4)"
717;19700174922;Chinese Journal of New Drugs;journal;10033734;0.111;Q4;12;555;1752;9599;145;1752;0.08;17.3;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
718;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.111;Q4;5;45;183;260;6;177;0.03;5.78;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
719;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.111;Q4;7;36;301;358;6;290;0.02;9.94;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
720;19700177006;Psychopharm Review;trade journal;19369255;0.111;Q4;4;2;36;103;7;36;0.17;51.5;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2009-2014;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
721;21000195625;Asian Journal of Pharmaceutical Research and Health Care (discontinued);journal;22501444, 22501460;0.11;Q4;6;12;39;263;5;32;0.14;21.92;India;Asiatic Region;;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
722;21100256959;Biomarkers and Genomic Medicine;journal;22140247;0.108;Q4;12;28;28;966;5;28;0.18;34.5;United States;Northern America;Elsevier BV;2013-2015;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
723;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;0.108;Q4;16;5;2;700;0;2;0;140;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
724;19700174886;Arzneimitteltherapie;journal;07236913;0.107;Q4;6;177;452;1016;14;225;0.04;5.74;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
725;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.107;Q4;22;104;191;2580;11;191;0.08;24.81;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology (Q4)
726;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.107;Q4;18;4;65;220;8;65;0;55;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
727;19900192735;International Drug Discovery;journal;21504806, 21504792;0.107;Q4;4;0;32;0;6;32;1;0;United States;Northern America;Russell Publishing LLC;2011-2012;Drug Discovery (Q4)
728;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.107;Q4;13;40;108;775;11;108;0.15;19.38;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
729;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.106;Q4;14;0;151;0;13;151;0.05;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
730;21100199794;Industrial Pharmacy;trade journal;17414911;0.106;Q4;4;16;59;110;6;59;0.05;6.88;United Kingdom;Western Europe;Euromed Communications;2011-2016;Pharmaceutical Science (Q4)
731;21100241763;International Journal of Green Nanotechnology;journal;19430906, 19430892;0.106;Q4;4;1;10;33;1;9;0.1;33;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2014;"Biomedical Engineering (Q4); Chemistry (miscellaneous) (Q4); Electrical and Electronic Engineering (Q4); Materials Science (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
732;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.106;Q4;7;223;764;3583;33;764;0.04;16.07;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
733;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.106;Q4;6;0;4;0;1;4;0.25;0;Netherlands;Western Europe;;;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
734;21243;Pharmacy Times;trade journal;00030627;0.106;Q4;8;254;841;1434;15;336;0.02;5.65;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
735;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.106;Q4;3;0;4;0;1;4;0;0;Russian Federation;Eastern Europe;JSC;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
736;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.105;Q4;18;372;406;7740;33;406;0.07;20.81;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
737;19200156912;EJHP Practice;trade journal;20303769, 17819989;0.105;Q4;6;0;92;0;6;70;0;0;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
738;21102;Pharmaceutical Journal;journal;00316873;0.105;Q4;28;334;1450;216;32;661;0.01;0.65;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
739;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.104;Q4;5;134;371;2001;14;371;0.03;14.93;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
740;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.104;Q4;2;0;109;0;2;64;0;0;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
741;19700175125;Internet Journal of Pharmacology;journal;15312976;0.104;Q4;8;0;6;0;0;6;0;0;United States;Northern America;Internet Scientific Publications, LLC;2009-2011;Pharmacology (Q4)
742;19700175061;Open Pharmacology Journal;journal;18741436;0.104;Q4;6;0;10;0;1;9;0.11;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
743;19700175002;Pharmaceutical Reviews;journal;19185561;0.104;Q4;5;0;6;0;0;6;0;0;Canada;Northern America;;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
744;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.104;Q4;13;0;151;0;10;136;0.05;0;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
745;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.103;Q4;8;0;41;0;4;35;0.05;0;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
746;22887;Chinese Journal of Antibiotics;journal;10018689;0.103;Q4;11;204;514;3060;28;511;0.04;15;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
747;19700175108;Drug Delivery System;journal;18812732, 09135006;0.103;Q4;8;60;83;778;3;83;0.02;12.97;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
748;21238;Drug Topics;journal;19378157, 00126616;0.103;Q4;8;285;751;118;6;83;0.01;0.41;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
749;17716;Quality Assurance Journal;journal;10991786, 10878378;0.103;Q4;9;0;13;0;2;11;0;0;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
750;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.102;Q4;10;36;90;1819;2;69;0.02;50.53;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
751;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.102;Q4;6;34;72;0;2;72;0;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
752;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;0.102;Q4;3;0;14;0;1;14;0;0;Poland;Eastern Europe;Grupa Dr. A. R. Kwiecinskiego;2010-2011;Pharmaceutical Science (Q4)
753;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.102;Q4;9;55;76;162;3;70;0.04;2.95;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q4)
754;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.102;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
755;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.102;Q4;9;0;10;0;0;10;0;0;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
756;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.102;Q4;5;58;97;1165;4;87;0.04;20.09;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
757;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.102;Q4;5;6;31;128;2;31;0;21.33;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
758;19700175034;Pharmaceutical Processing;trade journal;10499156;0.102;Q4;3;29;217;36;2;58;0.01;1.24;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
759;21100456702;3rd International Conference on Accelerating Biopharmaceutical Development 2013;conference and proceedings;-;0.101;-;1;0;17;0;1;16;0.06;0;United States;Northern America;;;Safety, Risk, Reliability and Quality
760;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.101;Q4;3;0;27;0;0;22;0;0;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
761;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.101;Q4;7;5;18;321;1;18;0.08;64.2;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
762;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.101;Q4;5;102;232;2657;6;227;0.01;26.05;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
763;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.101;Q4;4;126;459;173;4;413;0.01;1.37;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
764;21867;Geneesmiddelenbulletin;journal;03044629;0.101;Q4;7;48;187;837;4;100;0.02;17.44;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
765;21100829925;HiSTOReLo;journal;2145132X;0.101;-;3;24;22;786;1;17;0.05;32.75;Colombia;Latin America;Universidad Nacional de Colombia;2013-2021;History (Q3)
766;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.101;Q4;9;0;27;0;1;27;0;0;Nigeria;Africa;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
767;22977;Journal de Pharmacie de Belgique;journal;00472166;0.101;Q4;12;27;83;0;3;76;0.04;0;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
768;22979;Journal of Applied Therapeutic Research;journal;10292659;0.101;Q4;8;0;17;0;0;17;0;0;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
769;21077;Pharmaca;journal;00316857;0.101;Q4;5;0;19;0;0;17;0;0;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
770;21823;Pharmacia;journal;04280296;0.101;Q4;16;30;47;1091;1;47;0.03;36.37;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
771;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;2;5;52;19;0;34;0;3.8;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
772;5800207507;Side Effects of Drugs Annual;book series;03786080;0.101;Q4;6;108;105;9908;3;6;0.04;91.74;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
773;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;3;19;52;134;0;52;0;7.05;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
774;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;31;89;445;0;76;0;14.35;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
775;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;60;181;230;2;169;0.01;3.83;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
776;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.1;Q4;3;0;59;0;0;56;0;0;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
777;21100202747;GMP Review;trade journal;14764547;0.1;Q4;2;6;56;20;2;55;0.05;3.33;United Kingdom;Western Europe;Euromed Communications Ltd;2011-2015, 2017-2021;Pharmaceutical Science (Q4)
778;13637;Manufacturing Chemist;trade journal;02624230;0.1;Q4;6;91;376;146;2;335;0;1.6;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
779;21100348334;Pharmaceutical Discovery, Development and Manufacturing Forum 2013 - Core Programming Area at the 2013 AIChE Annual Meeting: Global Challenges for Engineering a Sustainable Future;conference and proceedings;-;0.1;-;1;0;74;0;1;72;0.01;0;United States;Northern America;;;"Organic Chemistry; Pharmaceutical Science"
780;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135, 19363435;0.1;Q4;1;0;87;0;1;87;0;0;United States;Northern America;Wiley-Blackwell;2010-2012;Pharmaceutical Science (Q4)
781;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;62;194;116;0;191;0;1.87;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
782;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.1;Q4;2;124;604;265;0;530;0;2.14;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
783;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;0;123;0;0;50;0;0;United Kingdom;Western Europe;Reed Business Publishing;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
784;20572;PZ Prisma;journal;09455566;0.1;Q4;5;37;104;722;1;92;0.01;19.51;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
785;16800154712;Sp2;trade journal;1476184X;0.1;Q4;2;37;123;16;0;103;0;0.43;United Kingdom;Western Europe;Avakado Ltd;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
786;21100853564;AAPS Advances in the Pharmaceutical Sciences Series;book series;22107371, 2210738X;;-;13;149;24;11482;6;23;0;77.06;Germany;Western Europe;Springer Verlag;2011, 2014-2021;Pharmaceutical Science
787;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;;-;65;9;5;129;12;1;2.4;14.33;Netherlands;Western Europe;Elsevier BV;2012, 2014-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
788;21100841779;ADMET and DMPK;journal;18487718;;-;15;25;8;853;4;5;0.5;34.12;Croatia;Eastern Europe;International Association of Physical Chemists;2013-2021;"Chemistry (miscellaneous); Health (social science); Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
789;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;;-;11;6;0;346;0;0;0;57.67;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science; Pharmacology"
790;21100853016;Antibodies;journal;20734468;;-;15;2;16;131;25;15;1.56;65.5;Switzerland;Western Europe;MDPI AG;2017-2021;"Drug Discovery; Immunology; Immunology and Allergy"
791;21100853960;Anti-Tumor Pharmacy;journal;20951264;;-;2;11;0;284;0;0;0;25.82;China;Asiatic Region;;2014-2016;"Oncology; Pharmaceutical Science; Pharmacology (medical)"
792;21100818733;Archives of Pharmacy Practice;journal;2045080X;;-;2;1;0;35;0;0;0;35;India;Asiatic Region;Wolters Kluwer Medknow Publications;2014, 2016;Pharmaceutical Science
793;21100455212;Biomedical Reports;journal;20499434, 20499442;;-;29;4;0;129;0;0;0;32.25;Greece;Western Europe;Spandidos Publications;2014-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
794;21100986051;Cancer Drug Discovery and Development;book series;21969906, 21969914;;-;5;18;0;2391;0;0;0;132.83;United States;Northern America;Springer New York;2014-2015, 2017-2020;"Cancer Research; Drug Discovery; Oncology"
795;21100873055;Cosmetics;journal;20799284;;-;27;20;0;537;0;0;0;26.85;Switzerland;Western Europe;MDPI AG;2014-2021;"Aging; Chemical Engineering (miscellaneous); Dermatology; Pharmaceutical Science; Surgery"
796;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;40;128;2804;239;121;1.78;70.1;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
797;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;35;96;1334;64;95;0.76;38.11;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
798;21100853873;International Journal of Current Pharmaceutical Research;journal;09757066;;-;5;1;0;21;0;0;0;21;India;Asiatic Region;Innovare Academic Sciences Pvt Ltd.;2014-2016;Pharmaceutical Science
799;21100788832;International Journal of Medicinal Chemistry;journal;20902069, 20902077;;-;4;2;0;107;0;0;0;53.5;United States;Northern America;Hindawi Publishing Corporation;2014-2016;"Biochemistry; Drug Discovery; Molecular Medicine"
800;21100854242;International Nano Letters;journal;22285326, 20089295;;-;1;1;0;18;0;0;0;18;United States;Northern America;Springer Science + Business Media;2014, 2019, 2021;"Bioengineering; Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
801;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;;-;24;20;0;560;0;0;0;28;Germany;Western Europe;Elsevier GmbH;2014-2021;"Drug Discovery; Plant Science"
802;21100902935;Journal of Biologically Active Products from Nature;journal;22311874, 22311866;;-;13;43;118;1293;27;118;0.23;30.07;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Agricultural and Biological Sciences (miscellaneous); Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science; Toxicology"
803;21101022494;Journal of Cardiovascular Development and Disease;journal;23083425;;-;21;19;0;1042;0;0;0;54.84;Switzerland;Western Europe;MDPI AG;2014-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
804;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;40;82;560;3;82;0.02;14;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
805;21100881509;Journal of International Pharmaceutical Research;journal;16740440;;-;7;120;138;2916;5;138;0.02;24.3;China;Asiatic Region;Editorial office of Journal of International Pharmaceutical Research;2010-2011, 2013-2020;Pharmaceutical Science
806;21100928216;Journal of Research in Pharmacy;journal;26306344;;-;16;25;77;793;27;77;0.36;31.72;Turkey;Middle East;Marmara University;2019-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
807;21100853985;Journal of Xenobiotics;journal;20394705;;-;2;2;0;53;0;0;0;26.5;Italy;Western Europe;PagePress Publications;2014-2016;"Pharmacology; Pollution; Toxicology"
808;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;273;822;6317;321;822;0.41;23.14;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
809;21100924771;Natural Products and Bioprospecting;journal;21922209, 21922195;;-;26;42;113;1438;131;113;1.2;34.24;Singapore;Asiatic Region;Springer Singapore;2011-2021;"Analytical Chemistry; Biochemistry; Food Science; Organic Chemistry; Pharmacology; Plant Science; Toxicology"
810;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;1;13;0;0;10;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
811;21100205919;Open Drug Discovery Journal;journal;18773818;;-;9;1;0;33;0;0;0;33;United Arab Emirates;Middle East;Bentham open;2010, 2014;Drug Discovery
812;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;;-;3;2;0;109;0;0;0;54.5;New Zealand;Pacific Region;Dove Medical Press Ltd.;2014-2015, 2017;"Drug Discovery; Pharmaceutical Science"
813;21100854648;Pharmaceutical Crops;journal;22102906;;-;1;1;0;158;0;0;0;158;Netherlands;Western Europe;Bentham Science Publishers B.V.;2014, 2016;"Pharmaceutical Science; Plant Science"
814;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;;-;13;5;0;357;0;0;0;71.4;Netherlands;Western Europe;Bentham Science Publishers B.V.;2014-2021;"Biomedical Engineering; Pharmaceutical Science"
815;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;9;74;585;153;69;2;65;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
816;19700174987;Research Journal of Toxins (discontinued);journal;18193560, 21517258;;-;3;1;0;30;0;0;0;30;United States;Northern America;Academic Journals Inc.;2009, 2014, 2016;"Agronomy and Crop Science; Food Science; Toxicology"
817;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;;-;10;18;0;1268;0;0;0;70.44;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2021;Drug Discovery
818;21100977423;RSC Medicinal Chemistry;journal;26328682;;-;62;231;595;10372;1542;576;2.48;44.9;United Kingdom;Western Europe;Royal Society of Chemistry;2020-2021;"Biochemistry; Drug Discovery; Molecular Medicine; Organic Chemistry; Pharmaceutical Science; Pharmacology"
819;21100787110;Therapeutic Advances in Psychopharmacology;journal;20451261, 20451253;;-;26;35;107;1033;139;69;1.32;29.51;United States;Northern America;SAGE Publications Inc.;2011-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Psychology (miscellaneous)"
820;21100367469;Toxicology Reports;journal;22147500;;-;46;124;0;5294;0;0;0;42.69;Ireland;Western Europe;Elsevier Scientific Publishers Ireland;2014-2021;"Health, Toxicology and Mutagenesis; Toxicology"
821;21100830708;Toxics;journal;23056304;;-;32;28;6;1815;7;5;1.17;64.82;Switzerland;Western Europe;MDPI AG;2013-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
